The BIophysical Basis for Adaptation: Predicting Evolutionary Outcomes from Physicochemical Properties by Benitez Cardenas, Andres
RICE UNIVERSITY 
The Biophysical Basis for Adaptation: Predicting Evolutionary 
Outcomes from Physicochemical Properties 
by 
Andrés Salvador Benítez Cárdenas 
A THESIS SUBMITTED  
IN PARTIAL FULFILLMENT OF THE  
REQUIREMENTS FOR THE DEGREE 
Doctor of Philosophy 
 APPROVED, THESIS COMMITTEE 
 
Yousif Shamoo 
Professor of Biochemistry & Cell Biology, 
Director of the Institute of Biosciences & 
Bioengineering 
 
Charles R. Stewart, Chair 
Professor of Biochemistry & Cell Biology 
 
Edward Nikonowicz 
Associate Professor of Biochemistry & 
Cell Biology 
 
Jonathan Silberg 
Associate Professor of Biochemistry & 
Cell Biology 
 
Laura Segatori 
Assistant Professor of Chemical & 
Biomolecular Engineering and  
Biochemistry & Cell Biology 
HOUSTON, TEXAS 
November 2012 
The Biophysical Basis for Adaptation: Predicting
Evolutionary Outcomes from Physicochemical
Properties
Andre´s Salvador Ben´ıtez Ca´rdenas
November 28, 2012
Abstract
Experimental evolution can be used in conjunction with biophysical characteriza-
tion of enzymes to determine the link between cellular fitness and physicochemical
properties of enzymes. Sequencing of ancestral and evolved populations can be used
to compare the outcomes of experimental evolution with measurements of fitness,
using growth rate assays to correlate fitness outcomes to specific mutations. Com-
bined with enzyme assays of kinetic properties that can provide a direct link between
genotypic and phenotypic changes of adaptive mutants, we can model the complex
relationship between genotypic changes and evolutionary outcomes.
Two experimental evolution systems were used to explore the link between enzyme
properties and fitness outcomes. In the first series of studies, a “weak link” evolution
experiment was used to explore the eﬀect of reducing selection strength on altering
accessible pathways for adaptation. In the “weak” link method the essential gene for
adenylate kinase (AK) was replaced in the chromosome of the thermophile Geobacillus
stearothermophilus with a homolog from Bacillus subtilis . Replacement with the mal-
adapted gene confers a high fitness cost, and therefore mutations that restore function
of AK are strongly favored. Two triple mutants of AK containing a new combina-
tion of single point mutants identified under strong selection, AKQ199R/A193V/Q16L and
AKQ199R/T179I/Q16L were discovered through an adaptation experiment using a weak
temperature ramp; suggesting that the adaptive landscape for AK thermostability
is highly constrained. A thermostable coupled assay was developed for measuring
adenylate kinase activity using LDHTT and PKGST at high temperatures. The triple
mutants had increased fitness compared with the double mutant ancestors, but the
triple mutants displayed negative epistasis eﬀects on fitness.
In the second experimental evolution system, a mathematical model was devel-
oped to investigate the role of adaptive mutations, in the tetracycline inactivation
enzyme TetX2, on antibiotic resistance to minocycline. Growth rate measurements,
enzyme kinetics, and flux balance analysis were used to develop a model to predict
the eﬀect on growth rates of TetX2 and seven adaptive TetX2 variants at diﬀerent
minocycline (MCN) concentrations. Population histogram measurements for the ex-
perimental evolution study were measured using a high throughput Illumina sequenc-
ing method(FREQ-SEQ). We found that the model was able to accurately predict the
fitness outcomes for the wild type and the seven single mutants of TetX2 that were
originally isolated, as well as for a double mutant that was not used in the develop-
ment of the original model. The mathematical model accurately predicts that the two
mutants TetX2T280A and TetX2N371I provide the largest fitness benefits, in agreement
with the results of flask experiments on adaptation to MCN. The model was also able
to accurately predict enzyme parameters from growth rate values, with a specific
emphasis on predicting the ratio of Vmax/KM(MCN). The model allows us to make
predictions about the fitness benefits of physicochemical changes to enzymes, and
can be used as a high throughput method for determining enzyme kinetic parameters
without requiring protein purification.
Understanding how physicochemical changes of enzymes relate to phenotypic
changes, and ultimately to fitness, requires knowledge of both the molecular basis
for determining enzyme properties, and how selection acts on fitness diﬀerences to
determine evolutionary outcomes. This research provides direct links between physic-
ochemical changes and adaptive phenotypes, as well providing observations of how
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adaptive landscapes and fitness changes aﬀect evolutionary outcomes.
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Chapter 1
Introduction
1.1 Mutations of Small Eﬀect Drive Adaptation
Adaptive evolution is driven by the accumulation of changes at the molecular level
that aﬀect the phenotype of the organism. Mutations that increase enzyme eﬃciency
and cause incremental fitness gains are enriched through natural selection. The un-
derstanding of the importance of small changes at the molecular level predates the
discovery of genetics. Darwin recognized that nature cannot make spontaneous jumps
in evolution; natural selection must act on small variations between organisms [Dar-
win, 1859]. However, he was unable to provide a mechanism for how infinitesimal
changes in variation become fixed in a population.
Kimura proposed that for a mutation to become fixed in the population it must
not only provide a beneficial eﬀect, but the fitness gain has to be large enough to
prevent the mutation from being lost through random eﬀects [Kimura, 1968, Orr,
2005]. The probability of a mutation with a beneficial eﬀect being lost by random
drift is dependent on selection strength and mutation frequency. Random genetic drift
9
and not adaptive evolution becomes a dominant factor in determining gene evolution
if fitness benefits are not strong enough to overcome random loss of adaptive mutants.
Alternatively, mutations that cause such a small change in protein function so as have
eﬀectively a neutral fitness eﬀect, can only become fixed in the population through
random chance.
Fisher was the first to propose a mechanism to link variation at the genetic level
to variation at the phenotypic level [Fisher, 1930]. Fisher proposed that beneficial
mutations of small phenotypic eﬀect are more frequent than beneficial mutations
of larger phenotypic eﬀect (1.1). Because mutations of larger phenotypic eﬀect have
higher probabilities of disrupting protein function, adaptation would be dominated by
mutations of small phenotypic eﬀect [Orr, 2006]. Since mutations that cause a small
change in phenotype are more numerous that mutations of greater phenotypic eﬀect,
mutations with small eﬀects on fitness will accumulate faster than large beneficial
mutations under non-selective conditions. Mutations that have a higher eﬀect on
fitness, although rare, have a higher probability of becoming fixed because they are
less likely to be lost under selection [Kimura, 1968]. Fisher’s geometric model of
the distribution of beneficial mutations provided a foundation for understanding the
mechanisms of evolution.
1.2 Mutation Rates Drive Adaptation
Under constant environmental conditions most genes under selection exist in a state
that provides high fitness, and because mutations will be predominately comprised
of single nucleotide mutations, adaptation to small disturbances in environment will
mostly be concerned with the extreme end of Fisher’s geometric distribution of mu-
10
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Figure 1.1: In this example an organism with two degrees of phenotypic change sits
at point A that is a distance z from a fitness optimum at point O. Mutations of
phenotypic eﬀect of size r will move the fitness of the organism randomly. Smaller
phenotypic eﬀect mutations (r1) have a higher probability of moving towards the
fitness optimum than mutations of larger phenotypic eﬀect (r2). Only mutations that
move the fitness of the organism inside the larger circle of radius z will be beneficial.
As the radius of circle r become smaller, corresponding to mutations of smaller size,
the fraction of mutations that will have beneficial eﬀects will be larger [Fisher, 1930].
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tations [Orr, 2006]. The mutation rate of Escherichia coli is about 8.9 ∗ 10−11 mu-
tations per base per generation for single nucleotide substitutions [Wielgoss et al.,
2011]. This translates to a mutation rate of 4 ∗ 10−5 mutations per E. coli genome
per generation. The mutation rate for spontaneous double mutants is much smaller
at 4 ∗ 10−5 × 4 ∗ 10−5. Insertions and deletions tend to be rare except at sequence
repeats, where they appear at a rate that is 1/10th the rate of single base pair sub-
stitutions [Lee et al., 2012]. Therefore, except for rare occurrences, natural selection
will mostly be driven by single substitutions [Orr, 2005,Gillespie, 1986].
Experiments involving mutator strains have shown that under stressful conditions
there is a linear increase in adaptation rate in response to an increase in mutation rate
[Arjan G et al., 1999]. If the population size is small enough that the rate of adaptation
is limited by the availability of beneficial mutations,f mutator strains will increase
the adaptation rate of a population [Gonzalez et al., 2008]. Mutator phenotypes can
then become enriched in the population by piggy-backing with adaptive mutations
[Denamur and Matic, 2006]. If the endogenous mutational diversity is high enough,
then there will be a suﬃcient amount of beneficial mutations present in the population
and the adaptation rate will not increase further [Arjan G et al., 1999]. Clonal
interference, where multiple beneficial mutations compete in the same population,
prevents further increase in adaptive rates since only the mutation providing the
largest fitness increase will rise to fixation [Tanaka et al., 2003].
Mutation rate has been shown to increase under stress, leading to an increase in
rates of adaptation [Galhardo et al., 2007,Gonzalez et al., 2008,Denamur and Matic,
2006]. Mutator phenotypes are not beneficial under stable environments because of
the possibility for the accumulation of detrimental mutations [Chattopadhyay et al.,
2009]. However, under stressful conditions, it can become beneficial to increase the
12
mutation rate to access rare beneficial mutations [Galhardo et al., 2007]. Rosenberg
has shown that under environmental stress the mutation rate of nucleotides near an
induced double stranded break on the Lac+ gene increased up to 4 fold [Gonzalez
et al., 2008]. Under conditions of stress the fidelity of the double strand break re-
pair mechanism is reduced causing a local increase in mutation rates. Other studies
have shown there are multiple mechanisms to increase mutation rates in response to
environmental stress [Galhardo et al., 2007].
1.3 Fitness Gains Taper After Initial Adaptive Steps
When an organism is introduced to a new environmental stress mutations of large
phenotypic eﬀect are favored because there is a large fitness gap between the original
gene sequence and potential mutational outcomes. Once beneficial mutations start to
accumulate the speed of evolution tapers as fitness gains become smaller [Elena and
Lenski, 2003,Chou et al., 2011,Khan et al., 2011,Nagel et al., 2012]. Due to neutral
drift, small mutations continue to accumulate at a linear rate although the fitness of
the population plateaus. [Elena and Lenski, 2003,Yu et al., 2009].
In a long-term evolution experiment by Richard Lenksi, replicate populations of
E. coli were adapted to grow in minimal media lacking glucose but containing citrate
as a carbon source [Elena and Lenski, 2003]. E. coli cannot utilize citrate as a carbon
source, so a gradual increase in fitness was observed except for one of the replicate
populations where the bacteria were able to evolve the ability to utilize citrate. A fit-
ness jump was observed when the bacteria accumulated the required mutations that
allowed the evolution of citrate utilization. The accumulation of potentiating muta-
tions was necessary to allow access to adaptive pathways that provided significant
13
increases in fitness. [Blount et al., 2008,Rendel, 2010]
1.4 Selection Strength Aﬀects Accessibility of Adap-
tive Mutations
Wright proposed the idea of an adaptive landscape as a method to visualize the sur-
face on which evolution happens [Wright, 1988]. A diﬀerent version of the adaptive
landscape was proposed by Smith, where, because of limitations set by the muta-
tion rate, proteins would typically adapt by single base substitutions [Smith, 1970].
While Smith’s model was concerned with protein sequences, his concept can be also
be applied to adaptation of DNA sequences [Orr, 2009, Sasaki and Nowak, 2003].
The adaptive landscape would then be composed of all possible genotypes so that
neighboring sequences diﬀer by single gene replacements [Orr, 2009]. At each step of
adaptation, natural selection would be able to sample only the sequences that diﬀer
by a single mutation [Orr, 2006]. Degeneracy in codon usage further limit the amino
acid replacements accessible from single mutations [Kimura, 1968]. Fitness can be
projected onto the surface such that the relative height of each node represents fitness
diﬀerences [Cooper and Lenski, 2010]. Natural selection will drive the organism up
the nearest fitness peak through the accumulation of beneficial mutations [Orr, 2005].
The shape of the adaptive landscape is also aﬀected by interactions between in-
dividual mutations [Perfeito et al., 2011,Chou et al., 2011,Lunzer et al., 2010]. Since
most mutations have epistatic interactions the adaptive landscape will tend to be
rugged, containing multiple local fitness peaks [Wright, 1988]. Epistasis is defined as
the non-additive eﬀects of two individual mutations on phenotype [Elena and Lenski,
2003]. The phenotypic eﬀect from two mutations can be greater or lesser than the
14
Figure 1.2: Adaptive landscape with two fitness peaks. Each node represents a single
mutational diﬀerence, pathways are limited to horizontal or vertical movements. A
two dimensional landscape represents a very simplified system with variation limited
two possible mutations at each step. Two diﬀerent pathways are shown, each leading
to a local fitness optimum. Once a fitness peak is reached, movement across the
landscape is limited since mutations will be detrimental.
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additive eﬀect of the individual mutations because of interactions between the two
mutations. Beneficial mutations show negative epistasis as they accumulate leading
to a decrease in adaptation rate [Chou et al., 2011, Nagel et al., 2012]. Additive
eﬀects on enzyme function decrease in fitness benefit as benefits from improving in-
dividual phenotypic eﬀects become saturated [Khan et al., 2011]. As the organism
approaches a fitness peak the beneficial eﬀect of individual mutations becomes smaller
due to epistasis [Hartl et al., 1985]. However, mutations that potentiate beneficial
mutations can appear through positive epistasis [Lunzer et al., 2010].
Positive epistasis between inter-protein mutations is commonly observed when
background mutations are required to allow a secondary mutation to have a benefi-
cial eﬀect on fitness [Weinreich et al., 2006,Kryazhimskiy et al., 2009]. For example,
compensatory mutations can increase the stability of a protein thus allowing for muta-
tions that increase activity but can have a destabilizing eﬀect on the protein [Coun˜ago
et al., 2008,Miller et al., 2006,Tokuriki et al., 2008]. The combined beneficial eﬀect of
both mutations is higher since the stabilizing mutation has a neutral eﬀect on fitness
by itself, and the initial mutations would have a decreased fitness benefit without the
compensatory mutation [Levin et al., 2000]. Epistasis has a role in limiting avail-
able pathways for evolution since the mutational background aﬀects the benefits of
subsequent inter-protein and intra-protein mutations [Weinreich et al., 2006].
Since the protein must remain functional at each step during adaptation, only
sequences that provide neutral or beneficial eﬀects can become fixed in the popula-
tion [Orr, 2005]. The adaptive walk of a protein sequence can be described as the
sequential progress of a protein from an area of low fitness to a local fitness peak due
to natural selection [Smith, 1970]. Selection strength, reflected by the slope of the
fitness peak, will aﬀect allowable intermediates for each step in the pathway [Eyre-
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Walker and Keightley, 2007]. Under a changing environment each intermediate must
be functional since only steps that are able to keep up with environmental changes
will be allowed [Collins et al., 2007]. Reducing the selection strength by limiting the
rate of environmental change allows mutations that provide smaller fitness benefits,
or neutral fitness eﬀects, to persist in the population. Adaptive pathways that stem
from initial weak mutations will be accessible under weaker selection conditions. The
height of fitness peaks and the ruggedness of the landscape will therefore be aﬀected
by selection strength.
1.5 Protein Function Balances Activity and Sta-
bility Trade-Oﬀs
There is an inherent trade oﬀ in activity and stability for protein function. Mutations
in the active site of a protein that increase activity have a tendency to be destabi-
lizing [Tokuriki et al., 2008]. Generally mutations that provide new function, such
as changing enzyme specificity, consequently have decreased stability [Wang et al.,
2002]. Increasing the rigidity of a protein as a result of an increase in stability, on the
other hand, can have an adverse eﬀect on activity [Arnold et al., 2001]. Experiments
using thermostable proteins have shown that an increase in stability often causes a
corresponding shift in the activity maximum of the enzyme [Coun˜ago et al., 2008].
Conversely, psychrophilic adaptation has been shown to lead to increased flexibility
of enzymes [Roovers et al., 2001]. Increasing stability has also been shown to enhance
the ability of enzymes to tolerate adaptive mutations [Bloom et al., 2006,Draghi et al.,
2010]. Robustness to destabilization from mutation has been shown to be a feature of
natural enzymes [Taverna and Goldstein, 2002]. Specifically increased protein stabil-
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ity can buﬀer proteins from the deleterious eﬀects of destabilizing mutations [Bloom
et al., 2005]. Because most mutations are destabilizing under neutral mutation stabil-
ity will be maintained by the accumulation of compensatory mutations in response to
destabilizing mutations accumulated through drift [Serrano et al., 1993, Soskine and
Tawfik, 2010]. Proteins under neutral evolution exist under equilibrium between the
necessity of flexibility for enzyme function and the requirements of excess stability
to provide a buﬀer to the accumulation of destabilizing mutations [DePristo et al.,
2005]. Adaptation to novel substrates [Wang et al., 2002] and adaptation to changing
environments [Coun˜ago et al., 2008] both often require mutations that have trade-oﬀs
between activity and stability for adaptation.
1.6 Historical Contingency Aﬀects the Stochastic-
ity of Evolution
The existence of multiple pathways for adaptation highlights an interesting question
about the repeatability of evolution [Gould and Eldredge, 1977]. How constrained
are outcomes of evolution if multiple pathways exist? Lenski’s 12 experimental pop-
ulations [Lenski et al., 1991] provide useful insights into the role of stochasticity in
determining evolutionary outcomes. They determined that the 12 experimental pop-
ulations shared mutations in similar genes or pathways, as well as having similar
increases in fitness [Yu et al., 2009,Lenski et al., 1991]. Other experiments have also
shown that under strong selection there are a limited amount of pathways available
for evolution [Wichman et al., 2000,Wood et al., 2005]. However, increasing the envi-
ronmental heterogeneity of the adaptive landscape produces a more rugged landscape
and, as a consequence, evolutionary outcomes become more stochastic [Cooper and
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Lenski, 2010].
Lenski was also able to provide proof for the role of historical contingency in evo-
lutionary outcomes [Blount et al., 2008] . If evolutionary outcomes are constrained
the starting point of a population becomes important in determining possible out-
comes of evolution [Travisano et al., 1995]. They were able to show that mutations
allowing citrate metabolism were only beneficial in certain backgrounds of evolved
populations [Yu et al., 2009]. Other experiments have also shown that mutations
with neutral or small eﬀects can be useful in allowing access to novel pathways for
evolution [Rendel, 2010].
1.7 A Biophysical Basis for Adaptation
The causal relationship between physical properties of enzymes and their relative
eﬀects on fitness must be established to fully understand the rules that govern nat-
ural selection. The interaction between genotype and phenotype is complex and
causality is hard to determine [Dykhuizen et al., 1987]. Diﬀerent genotypes can have
the same phenotypic eﬀect, and the same genotype under diﬀerent environments
can have diﬀerent eﬀects on phenotype [Dykhuizen and Dean, 1990]. Determina-
tion of functional polymorphisms is further complicated by the large fitness eﬀect
that can occur from relatively small functional eﬀects [Eanes, 1987]. However, the
system can be simplified by controlling experimental conditions in laboratory evolu-
tion experiments [Kawecki et al., 2012,Coun˜ago et al., 2006]. Evolution experiments
can be designed to target specific phenotypic changes by controlling selection condi-
tions [Lenski et al., 1991]. Population size [Campos and Wahl, 2009,Barrett et al.,
2006] and mutation rate [Camps et al., 2003, Gonzalez et al., 2008, Chattopadhyay
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et al., 2009] can also be used to control mutation frequency as well. Enzyme variants
from experimental or natural populations can be characterized to measure physical
properties such as protein stability and activity [Coun˜ago et al., 2006]. Diﬀerences in
variation of enzyme properties can then be compared to population measurements to
make correlations about the fitness eﬀects of enzyme variants [Pen˜a et al., 2011].
The mechanistic approach to studying evolution was described by Dean and
Thornton as the “functional synthesis” [Dean and Thornton, 2007]. Dean and Thorn-
ton described a growing synergy between approaches in molecular biology, biochem-
istry , and experimental evolution to elucidate the complex relationship between geno-
type and phenotype. Hypothesis generated from the results of evolution experiments
can be tested through biophysical comparisons of enzyme variants and their resulting
eﬀects on phenotype [Storz and Wheat, 2010] . The development of high throughput
DNA sequencing allows us to identify changes in gene sequences as well as provides
mechanisms for measuring population distributions [Ragoussis, 2006, Chubiz et al.,
2012]. Genes from evolved populations can be cloned into the ancestral genome, iso-
lating any change in fitness from the targeted gene [Stepanova et al., 2008,Coun˜ago
et al., 2006,Weinreich et al., 2006]. High resolution protein structures determined by
X-ray crystallography or NMR can be coupled with measurements of enzyme kinetics
to determine the physicochemical properties of enzymes [Coun˜ago et al., 2008,Pen˜a
et al., 2010,Newcomb et al., 1997].
1.8 Flux Analysis Can Predict Fitness Outcomes
Mathematical models of metabolite flux through the cell can be used to predict growth
rates and fitness [Lewis et al., 2010, Pen˜a et al., 2011]. Measurable changes in the
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physical properties of cells are correlated to measurable changes in overall fitness
through a growth rate function based on metabolic flux analysis [Dykhuizen and
Dean, 1990,Orth et al., 2010]. The flux through a metabolic pathway is related to
the activity of the individual enzymes [Dykhuizen et al., 1987]. The fitness function for
flux through a limiting metabolic pathway will be concave as the eﬀects of increasing
flux thorough an enzyme will diminish as metabolism becomes saturated [Hartl et al.,
1985]. Dykhuizen was able to measure the relative eﬀects on fitness of beneficial
mutations in a lactose utilization pathway by comparing lactose utilization mutants
isolated from adapting E. coli to grow under lactose limited media in a chemostat. He
was able to show that an increase in β-galactosidase permease activity had a larger
eﬀect on fitness than the same increase in activity in β-galactosidase [Dykhuizen et al.,
1987]. The rate of flux through multiple metabolic systems can also be shown to be
proportional to the relative amounts of enzyme concentrations [Rossell et al., 2011],
allowing analysis of eﬀects of phenotypic variation on the genotype scale [Lerman
et al., 2012]. Analysis of metabolite flux provides a powerful system for understanding
correlations between the physical properties of enzymes and behaviors of populations
undergoing evolution [Eanes, 1987,Dekel and Alon, 2005, Lunzer et al., 2002, Ibarra
et al., 2002].
1.9 Focus of the Work
The goal of this dissertation is to unite physical changes to fitness and, in turn, to
predict success in an evolving population. We are interested in following the path
from molecular changes to their eﬀect on the overall fitness of the organism. To un-
derstand the causal pathway from protein changes to fitness changes we must be able
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to compare fitness measurements to measurable changes in physical properties of en-
zymes. Understanding the complete pathway relies in uniting “top down” approaches
that elucidate the end results of adaptation, with “bottom up” approaches that seek
to provide a reasoning for the mechanisms that provide fitness diﬀerences. Random
mutagenesis and experimental evolution techniques were used to provide a source of
enzyme variants with measurable fitness diﬀerences. Enzyme kinetics and stability
measurements were then used to uncover physical properties of enzyme variants to
determine the link between physical properties and fitness. We compared the proper-
ties of enzymes to measurements of population dynamics during evolution to provide
insights into mechanisms determining evolutionary outcomes.
We elucidated the link between evolutionary outcomes and enzyme properties
using two diﬀerent experimental evolution systems. Evolution of thermostability in
a turbidostat under weak selection conditions was used to test how the ruggedness
of the adaptive landscape aﬀects possible outcomes for evolution. Measurements of
the shift of the temperature profile for stability and activity in response to changing
temperature were then used to investigate the eﬀect of the ruggedness of the fitness
landscape on determining adaptive walks. Mathematical modeling was then used to
investigate the role of small changes in physical properties of enzymes on determining
fitness changes. We used the mathematical model to determine a fitness function to
predict growth rates for an enzyme that provides resistance to growth rate inhibition
by antibiotics and used enzyme variants to determine model parameters. We were
then able to show that the same model can be used to determine kinetic properties
from growth rates.
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1.10 The “Weak Link” Method for Studying Evo-
lution
Replacement of an essential gene in the chromosome with a maladapted homologue
can focus adaptation of the targeted gene under the appropiate selection conditions.
The replaced gene becomes a “weak link” preventing the cell from growing at maxi-
mum growth rate [Coun˜ago et al., 2006]. Mutations that restore function of the gene
will provide a large fitness benefit and will be strongly favored. The essential protein
adenylate kinase was replaced in G. stearothermophilus with the homologue from B.
subtilis to create our “weak link” system [Coun˜ago et al., 2006]. Adenylate kinase
was chosen as our target enzyme because it is necessary for maintaining adenylate
homoestasis [Atkinson, 1968]. Growth rate can be shown to be dependent on the
concentration of high energy phosphorylated adenylate species present in the cell,
which is dependent on proper adenylate kinase function [Swedes et al., 1975]. The
energy charge of the cell (EC) is defined as the fraction of high energy phosphorylated
adenylate species to lower energy species [Atkinson, 1968], is the availability of the
high energy phospohrylated species [Atkinson and Walton, 1967].
EC =
ATP + 12ADP
ATP + ADP + AMP
(1.1)
Adenylate kinase is required to regenerate ADP by catalyzing reaction R 1.1.
ATP + AMP −−￿￿− 2ADP (R1.1)
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ATP can then be regenerated by ATP synthases.
ADP + Pi −−￿￿− ATP + H2O (R1.2)
Without proper adenylate kinase function the cell lacks other eﬃcient mechanisms
for regenerating ADP, leading to an inability to produce ATP and a decrease in
the EC of the cell [Pen˜a et al., 2010]. The function of adenylate kinase is tightly
controlled since adenylate nucleotide concentrations are essential regulators of cellular
metabolism [Hardie and Hawley, 2001,Atkinson and Walton, 1967]. Proper adenylate
kinase function is therefore essential for cell survival, and furthermore, a decrease in
AK function will lead to a proportional decrease in cell metabolism because of the
reduction in EC of the cell [Atkinson, 1968,Swedes et al., 1975,Pen˜a et al., 2010].
The crystal structure of adenylate kinase from B. subtilis reveals that the cat-
alytic domain consists of two binding pockets for the two substrates and a lid do-
main [Saint Girons et al., 1987]. Flexibility of the enzyme, and especially of the lid
domain, has been shown to be essential for proper function of the enzyme [Vonrhein
et al., 1995]. Adenylate kinase adaptation to function at high temperatures requires a
balance of increased thermal stability without compromising the required flexibility of
the enzyme [Coun˜ago et al., 2008]. The lid domain closes over the site of phosphoryl
transfer to prevent hydrolysis of ATP by water [Mu¨ller et al., 1996].
A temperature sensitive strain of G. stearothermophilus NUB3612-R was cre-
ated through a chromosomal replacement of AK(GSTE) with AK(BSUB) [Coun˜ago and
Shamoo, 2005]. Comparison of the structures ofG. stearothermophilus AK (AK(GSTE))
and B. subtilis AK (AK(BSUB)) reveals that the thermophilic enzyme is more rigid at
lower temperatures due to an increase in the strength of electrostatic interactions [Bae
and Phillips Jr, 2004]. The two enzymes share 74% amino acid sequence and have
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Figure 1.3: Structure of adenylate kinase mutant Q199R in complex with the in-
hibitor diadenoside pentaphosphate (Ap5A) [Coun˜ago et al., 2006]. Ap5A binds to
both the ATP and AMP binding pockets. The structure is presented in the closed
conformational state [Saint Girons et al., 1987].
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similar structural identity, however, the thermal denaturation midpoints (TM) are
significantly diﬀerent: AK(BSUB) TM is 47.6￿ and AK(GSTE) TM is 74.5￿ [Bae and
Phillips Jr, 2004]. The growth range for strain G. stearothermophilus NUB3621-
R:ThEV is limited to below 55 ￿ compared to the wild type optimal growth tem-
perature of 68￿ [Coun˜ago and Shamoo, 2005]. Mutants that rescued the tempera-
ture sensitive phenotype of G. stearothermophilus NUB3621-R:ThEV were recovered
through an evolution experiment utilizing a turbidostat. A turbidostat is a type of
bacterial continuous batch reactor where the cell density is kept constant by regu-
lating the nutrient flow into the reactor vessel [D E Dykhuizen, 1983]. The bacteria
were grown under a temperature ramp of 0.5￿ per day from an initial temperature
of 55￿ over 30 days to a final temperature of 70￿ [Coun˜ago et al., 2006]. The
mutant AKQ199R was isolated at 55￿ from the first sample taken from the reactor
vessel. AK(BSUB)Q199R has significantly increased stability and activity compared to
WT AK(BSUB) at 55￿. AK(BSUB) has a maximum activity that is between 55￿ and
60￿ [Pen˜a et al., 2011,Coun˜ago et al., 2008]. The population in the vessel remained
stable until 60￿ when AK(BSUB)Q199R was replaced in the population by a series
of double mutants. The double mutants competed in the population with varying
degrees of success until 68￿ when one double mutant, AK(BSUB)Q199R/Q16L, became
fixed in the population. The triple mutant increased the stability over 10￿ com-
pared with WT AK(BSUB) [Coun˜ago et al., 2006]. Further studies of the 6 AK(BSUB)
variants show that each of the mutants shifts the temperature optimum for each mu-
tant to a higher temperature, with AK(BSUB)Q199R/Q16L showing the largest shift in
activity [Pen˜a et al., 2011].
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1.11 Antibiotic Resistance Provides a Controlled
Environment to Study Adaptation
Antibiotic resistance is a compelling target for laboratory evolution experiments both
because it provides clinical relevance, and selection strength can be changed read-
ily. [Elena and Lenski, 2003,Dykhuizen and Dean, 1990,Charusanti et al., 2012]. The
rise of antibiotic resistance over the last 50 years due to widespread use [Livermore,
2003] has led to increased interest in the discovery of novel antibiotics and antibiotic
targets [Cohen, 2000, Boucher et al., 2009]. There is also a resurgence of emphasis
on the control and treatment of infectious diseases due to the accelerating spread of
multi-drug resistant bacteria and the reduction in the development of novel thera-
peutic antibiotics [Cohen, 2000,Boucher et al., 2009]. The global rise during the last
decade of multi drug resistant Staphylococcus aureus [Boucher et al., 2009], drug re-
sistant respiratory pathogens [File, 2006], and multi and pan resistant Gram-negative
bacilli [Giske et al., 2008] underscores the importance of antibiotic resistance at the
forefront of health care issues [Spellberg et al., 2008]. The role of broad spectrum
antibiotic resistance enzymes and membrane eﬄux pumps in providing multi-drug
resistance to bacteria highlights the importance of focusing on understanding mech-
anisms for antibiotic resistance [Alekshun and Levy, 2007]. Laboratory evolution
experiments provide a unique environment to explore both the mechanisms bacte-
ria use to adapt to antibiotics, as well as to help predict new sources of antibiotic
resistance. Experiments using directed evolution have been able to recapitulate the
appearance of mutations that have clinical relevance [Weinreich et al., 2006,Orencia
et al., 2001] as well as to help understand the interactions between mutations that
confer resistance [Oelschlaeger, 2008].
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Development of antibiotic resistance provides a good system for investigating
mechanisms of adaptation such as, the role of compensatory mutations in reduc-
ing the cost of antibiotic resistance [Lenski, 1998, Wang et al., 2002], or the role
of mutation strains on enhancing rates of adaptation [Levin et al., 2000,Bjorkholm
et al., 2001]. Resistance to antibiotics can be used to provide a strong selection to
allow the isolation of adaptive mutants [Barlow and Hall, 2002,Orencia et al., 2001].
Selection can also be controlled by changing antibiotic concentration or changing
the rate of the antibiotic concentration ramp. Fitness gains can be easily quanti-
fied by measuring growth rate under diﬀerent antibiotic concentrations [Weinreich
et al., 2006, Vakulenko et al., 1998]. Stemmer showed that experimental evolution
using β-lactamase can be used to predict possible pathways for antibiotic resistance.
He used DNA shuﬄing and recombination to find variants of TEM-1 β-lactamase
with increased resistance to cefotaxime [Stemmer, 1994]. He found that the triple
mutant E104K/M182T/G238S produced a 500-fold increase resistance over the wild
type sequence. This same triple mutant was identified as clinical isolate TEM-52 [Po-
yart et al., 1998]. The available pathways for antibiotic resistance seem to be highly
constrained, comparable to other natural and directed evolution experiments, pre-
sumably due to strong selection conditions [Wichman et al., 2000]. Weinreich et al.,
used a library of combinations of these and other well known TEM-1 mutations to
investigate the role of epistasis in antibiotic resistance [Weinreich et al., 2006]. They
created all possible combinations of 5 mutations to the TEM-1 β-lactamase gene,
and measured the minimum inhibiting concentration (MIC) of cefotaxime for each
combination as a proxy for fitness. They were able to show that epistasis between the
5 mutations limited available pathways for adaptation to less than 10% of the total
available outcomes. Evolution of antibiotic resistance has also been used to answer
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questions about the mechanisms that drive adaptation [Barlow and Hall, 2002,Zhang
et al., 2011]. Our goal is to use adaptation to the tetracycline derivative minocycline
by bacteria containing the tetracycline resistance protein TetX2 to create a growth
rate function that can predict how functional diﬀerences in protein function translate
to antibiotic resistance.
1.12 Modeling of Mechanisms of Evolution using
Antibiotic Resistance
Tetracycline class antibiotics are broad spectrum bacteriostatic antibiotics aﬀecting
both Gram positive and Gram negative bacteria [Chopra and Roberts, 2001]. Tetra-
cycline antibiotics inhibit protein synthesis by binding to the A (aminoacyl) site of
the 30S ribosomal protein blocking binding of amino-acyl tRNA [Brodersen et al.,
2000, Chopra and Shales, 1981, Spahn and Prescott, 1996]. Specifically tetracycline
binds to the sugar phosphate backbone of the 16S RNA [Brodersen et al., 2000].
There are, however, other secondary sites where tetracycline is known to interact
with the 30S subunit, and it is unknown if these sites are relevant for antibiotic
activity [Brodersen et al., 2000, Pioletti et al., 2001]. Tetracyclines cross the outer
membrane of gram negative bacteria through the OmpF or OmpC porin channels as
a positively charged complex with magnesium (Mg2+) [Nikaido and Thanassi, 1993].
The Donner potential, the unequal distribution of ionic species across a membrane,
causes an accumulation of tetracycline in the periplasm [Thanassi et al., 1995]. Tetra-
cyclines dissociate from Mg2+ once in the periplasm [Thanassi et al., 1995]. Since
tetracycline is weakly lipophilic the uncharged species can cross the inner membrane
into the cytoplasm [Sigler et al., 2000]. Tetracycline becomes chelated to Mg2+ in
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(a) Tetracycline
(b) Minocycline
Figure 1.4: The structures of a) tetracycline and b) minocycline. The hydrophilic
functional groups and the 4 ring system are conserved among tetracycline variants
and required for function. Reprinted by permission from the American Society for
Microbiology: Microbiology and Molecular Biology Reviews [Chopra and Roberts,
2001] Copyright (2001).
the cytoplasm due to the pH gradient across the inner membrane, causing further ac-
cumulation inside the cytoplasm [Chopra and Roberts, 2001,Nikaido and Thanassi,
1993, Sigler et al., 2000]. Minocycline is a tetracycline derivative that has increased
hydrophobicity compared with tetracycline [Chopra and Roberts, 2001], resulting in
increased transport into the cell .
Resistance mechanisms for tetracycline can be separated into groups by their mode
of action. Most of the genes conferring tetracycline resistance are in the form of eﬄux
pumps, which protect the ribosome by reducing the intracellular concentration of
tetracycline, and including TetA. Ribosomal protection proteins, such as TetM, work
by preventing binding of tetracycline to the ribosome either by directly inhibiting
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(a) (b)
Figure 1.5: Tetracycine shows either a) 2 [Brodersen et al., 2000] or b) 6 [Pioletti et al.,
2001] binding sites for the 30S ribosomal subunit. The primary site in figure a and the
Tet-1 site in figure b show nearly identical binding interactions, while the secondary
site and Tet-5 site show similar but distinct binding [Pioletti et al., 2001]. The primary
site is near the amino-acyl tRNA binding site (site A) of the ribosome and is predicted
to be the main source of ribosome inhibition [Brodersen et al., 2000]. Reprinted
by permission from American Society of Microbiology: Antimicrobial Agents and
Chemotherapy [Connell et al., 2003], copyright (2003).
tetracycline binding or by promoting the release of tetracycline after binding to the
ribosome [Connell et al., 2003]. TetX2 is the only known tetracycline resistance
protein that works by enzymatic degradation of the antibiotic [Chopra and Roberts,
2001].
TetX was first identified in two related transposons, Tn4351 and Tn4400, from
Bacteroides fragilis [Speer et al., 1991]. Two other tetX homologues (tetX1 and
tetX2 ) were identified in the transposon CTnDOT from Bacteroides thetaiotaomicron
[Whittle et al., 2001]. The first of the two tetX genes in CTnDOT, tetX1 shares
66% amino acid identity to TetX, however, tetX2 shares 99% amino acid identity
with TetX [Speer et al., 1991]. TetX2 regioselectively hydroxylates tetracycline at
the C11a position [Yang et al., 2004]. The enzyme is a monooxygenase-containing
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Figure 1.6: Structure of TetX2 and FAD cofactor with substrate analog [Walkiewicz
et al., 2012].
a flavin cofactor, which is required for proper function [Moore et al., 2005]. Upon
hydroxylation, tetracycline is unstable and degrades non-enzymatically [Yang et al.,
2004]. The enzyme requires NADPH and O2 to re-oxidize the flavin cofactor after
each reaction [Yang et al., 2004]. The tetracycline derivative minocycline is a good
target for adaptation since wild type tetX2 has low activity towards minocycline
compared with other tetracyclines [McMurry et al., 1982].
1.13 Goals for the thesis
We used the “weak link” method to investigate the eﬀects of selection strength on
accessible adaptive pathways. Using the thermolabile strain of Geobacillus stearother-
mophilus , we isolated novel mutants of adk by modifying the selection strength of the
turbidostat experiments. We also developed a novel assay for measuring enzyme ki-
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netics of the thermostable adenylate kinases. This assay was used to measure the
activity of the novel mutants of adenylate kinase and, coupled with measurements
of stability, used to compare the properties of the enzymes identified from the weak
selection experiment with those identified previously.
The second goal of the thesis was to develop a growth rate function to predict the
eﬀects of changes in the enzymatic properties of TetX2 on degradation of minocy-
cline on and consequently, on growth rates and fitness. Growth rates and kinetic
measurements of 8 mutants that were identified though directed evolution were used
to develop a growth rate function to predict fitness eﬀects. Enzyme properties of
mutants were predicted from growth rates using the growth rate function to prove
the reversibility of the model. The relative importance of KM(MCN). KM(NADPH), and
Vmaxon determining growth rates was determined by analyzing the response of the
model to changes in these parameters.
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Chapter 2
Materials and Methods
2.1 Construction of plasmids for the expression
of Thermus thermophilus L-lactate dehydro-
genase (LDHTT) and Geobacillus stearother-
mophilus pyruvate kinase (PKGST)
T. thermophilus genomic DNA was a gift from Dr. J. Silberg (Rice University).
The lactate dehydrogenase gene (GI:55772495) was cloned into pET-28b (Novagen)
with an N terminal HIS-tag (pLDHTTHERMOPHILUS). The pyruvate kinase gene from
Geobacillus stearothermophilus (GI:285623) was synthesized (Genescript) after codon
optimization for expression in Escherichia coli . The synthetic gene was subcloned
into pET-28b with an N terminal HIS-tag for expression in E. coli using NdeI and
HindIII restriction sites (pPKGSTEAROTHERMOPHILUS).
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2.2 Purification of LDHTT and PKGST
One Shot DE3 BL21 star E. coli cells (Invitrogen) were transformed with either
the pLDHTTHERMOPHILUS or pPKGSTEAROTHERMOPHILUS vector. Cells were grown in
LB media containing 50 µg/ml kanamycin to an approximate OD of 0.6 at 37￿.
Induction was initiated by the addition of IPTG to 0.5 mM. After 6 hours, cells were
pelleted by centrifugation at 10,000g for 30 minutes. The pellet was resuspended in
buﬀer containing 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 10 mM MgCl2, and 30 mM
Imidazole pH 8.0. Cells were lysed by sonication and cell debris removed subsequently
by centrifugation at 15,000g.
HisBind resin (Novagen) was used to purify LDHTT and PKGST following the
manufacturer’s protocols (column volume = 10 ml). The supernatant from the lysed
cells was loaded onto the resin and washed with 3 column volumes of wash buﬀer (20
mM Tris-HCl buﬀer pH 7.5, 1 M NaCl, 40 mM Imidazole pH 8.0). The protein was
eluted with 4 column volumes of a buﬀer containing 20 mM Tris-HCl buﬀer pH 7.5,
0.5 M NaCl, 0.5 M imidazole pH 8.0, 0.2 mM PMSF, and 5 mM β-mercaptoethanol.
Purity was estimated to be greater than 85% by SDS-PAGE. Fractions containing
PKGST of LDHTT were pooled and dialyzed into 50 mM Tris-HCl buﬀer pH 7.5, 30
mM imidazole pH 8.0, and 150 mMNaCl. LDHTT was dialyzed into a high salt storage
buﬀer to reduce precipitation (50 mM Tris-HCl buﬀer pH 7.5, 150 mM Imidazole pH
8.0, and 500 mM NaCl). AK(BSUB) purification was purified as described previously
[6]. Protein concentrations were estimated from the calculated extinction coeﬃcients
of 13,075 M-1cm-1 for PKGST and 27,515 M-1cm-1 for LDHTT.
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2.3 Characterization of PKGST and LDHTT
Temperature and substrate dependent activities of PKGST and LDHTT were deter-
mined over a range of temperatures. All assays were performed in Reaction Buﬀer
(50 mM potassium phosphate buﬀer pH 7.5, 65 mM KCl and 5 mM MgCl2). The
Reaction Buﬀer for each concentration was incubated for 5 minutes at each tem-
perature. The reaction rates of LDHTT were measured at 45, 50, 60, 70, and 75￿
with 0.3 mM NADH for pyruvate concentrations of 1000, 750, 500, 100, 50, 10, and
5 µM respectively. To initiate the reaction LDHTT was added after equilibration,
and product formation (NAD+) was quantitated spectrophotometrically at 340 nm.
The initial reaction rate (v0) was measured from the slope of the measured reaction
curve for the first 6 seconds after placing the cuvette into the spectrophotometer.
The reaction rates of PKGST were measured at 45, 50, 60, 70, and 75￿ with 2.0 mM
phosphoenolpyruvate (PEP), 0.3 mM NADH and ADP concentrations of 1000, 750,
500, 100, 50, 10, and 5 µM respectively. 0.5 µM LDHTT was added to the PKGST
assay mixture at 50, 60, 70, and 75￿. However, at temperatures below 50￿, 1.0 µM
LDHTT was required. PKGST was added after the 5 minute incubation to initiate the
reaction, and the rate of NADH consumed was measured at 340 nm. The plot of v0
as a measure of pyruvate or ADP concentration for LDHTT and PKGST were fitted
to the Michaelis-Menten equation to calculate the maximum velocity (Vmax) and KM
using the software program Graphpad Prism.
2.4 Adenylate Kinase Protein Purification
Adenylate kinase was expressed in One Shot DE3 BL21 star E. coli transfromed with
pET11aAK(BSUB) . 2 L of cells in LB media containing ampicillin at a concentration of
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100 µg/ml were grown at 37￿ until and OD of 0.6 to 0.8 was reached. The media
was then centrifuged at 10,000 rpm for 20 minutes to pellet the cells, and frozen
overnight. The cells were resuspended in 40 ml resuspension buﬀer (buﬀer A). Buﬀer
A contains 50 mM Tris buﬀer pH 7.5, 1 mM NaCl, 1mM MgCl, 0.1 mM EDTA, and
0.3 mM DDT. The cell pellet was thawed for 20 minutes on ice before sonication.
Resuspended cells were sonicated for 4 times on output control 7, duty cycle 70, for
2 minutes on/2 minutes oﬀ schedule for a total of 8 minutes of sonication. The cells
were then centrifuged at 16,000 rpm for 25 minutes at 6￿.
The first purification step was on a Q Sepharose HP column. Pressure limit was
set to 0.5 MPa. The column was washed first with 1 column volume (CV) of buﬀer
A, 50 ml total. A second was with 1 CV of a high salt buﬀer (buﬀer B) was run
through the column. Buﬀer B is identical to buﬀer A except containing 1 M NaCl.
Finally the column was equilibrated with 5 CV’s of buﬀer A. The protein was filtered
through a 0.22 µm filter before being loaded into the column. Sample was injected
to 40 ml. A gradient from buﬀer A to 30% buﬀer B was run on the column, and the
column flow was then held ad 30% buﬀer B. Column flow was fractionated into 5 ml
volumes. The UV spectrum was used to identify fractions containing the protein.
Column fractions were pooled and the solution dialyzed into buﬀer A with 20 mM
tris. The second step of purification was to run the protein through a blue sepharose
aﬃnity column. The column was washed with 10 CV’s of ddH2O (CV of 50 ml). A
second wash step was done with 2 CV’s buﬀer A. Dialyzed protein was concentrated
to 5 to 10 ml and was added to the column. The column was washed with 8 CV’s of
buﬀer A until the OD from the UV spec at 280 nm was less than 0.1. Protein was
eluted by using a mix from 0% to 100% buﬀer B (in buﬀer A) solution over 20 CV’s.
Eﬄux was fractionated into 5 ml fractions and the OD was measured and fractions
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were collected until the OD was below 0.5. Fractions were run on a 17% SDS-page
gel for 1:30 minutes at 80V and the fractions containing protein were pooled and
dialyzed overnight into 20 mM pH 7.0 HEPES buﬀer.
A Superdex gel filtration column was used for the last purification step. The
column was run with a buﬀer of 20 mM HEPES pH 7.4 and 0.2 M NaCl. A flow
rate of 0.5 ml/min was run on the column. Volume fractions of 2 ml were collected
and the column was run until the protein was fully eluted. The fractions containing
protein were run on an SDS page gel and fractions containing protein were pooled.
The protein was dialyzed into 20 mM HEPES overnight. AK was concentrated to an
OD/ml of 30. Protein purification usually resulted in around 100 mg total protein.
The extinction coeﬃcient for AK(BSUB) used was 12,345 M-1cm-1.
2.5 Quantitation of Kinase Activity at 45-75￿by
the LDHTT/PKGST Coupled assay
All assays were performed in Reaction Buﬀer (50 mM potassium phosphate buﬀer pH
7.5, 65 mM KCl and 5 mM MgCl2). The reaction rates of AK(BSUB) were measured at
1.4 mM AMP, 2 mM PEP, and 0.3 mM NADH for ATP concentrations of 1000, 750,
500, 100, 50, 10, and 5 µM respectively. The concentration of AK(BSUB) was 5 nM for
all reactions. For the AK(BSUB) measurements the reaction buﬀer was incubated for 5
minutes to the correct temperature with 0.5 µM LDHTT and 24 µMPKGST. To reduce
ATP hydrolysis ATP was added just prior to AK(BSUB)to initiate the reaction. The
initial reaction rate v0 was measured in the same manner as for LDHTT and PKGST.
The plot of v0 vs ATP was fitted to the Michaelis-Menten equation in Graphpad
PRISM to calculate Vmax and KM (Figure 3).
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2.6 Numerical Simulation of the Coupled Assay
A numerical simulation using MATLAB was used to predict how the concentrations
of the substrates varied during the reaction using single substrate and simple bi-
substrate Michaelis-Menten kinetics. The reaction rates for PK, AK, and LDH were
modeled using the Michaelis-Menten equation for a bi-substrate reaction with random
substrate binding as described in equations 2.1, 2.2 and 2.3 respectively.
vAK =
vmax[ATP][AMP]
kATPM k
AMP
M + k
AMP
M [ATP] + k
ATP
M [AMP]
(2.1)
vPK =
vmax[ADP][PEP]
kADPM k
PEP
M + k
PEP
M [ADP] + k
ADP
M [PEP]
(2.2)
vLDH =
vmax[Pyruvate][NADH]
kPyruvateM k
NADH
M + k
NADH
M [Pyruvate] + k
Pyruvate
M [NADH]
(2.3)
The rate of change in concentration of each of the products and substrates at time
t can be calculated by using the enzyme specific activity v. ATP is the substrate of
the AK reaction (2.1 and the product of the PK reaction (2.2).
∂[ATP]
∂t
= vPK − vAK (2.4)
Similar equations exist for the other substrates AMP, ADP, PEP, Pyruvate, and
NADPH.
∂[AMP]
∂t
= −vAK (2.5)
∂[ADP]
∂t
= vAK − vPK (2.6)
∂[PEP]
∂t
= −vPK (2.7)
39
∂[Pyruvate]
∂t
= vPK − vLDH (2.8)
∂[ADP]
∂t
= −vLDH (2.9)
A Euler approximation was used to calculate the solution of the series of partial
diﬀerential equations with a step size of 10-3. The experimental concentrations of
the substrates and enzymes were used as the initial conditions for the numerical
simulation. The initial values used were: AMP 1400 µM, ADP 0, PEP 2000 µM,
Pyruvate 0, and NADH 300 µM. The values used for the kinetic parameters of AK
were: Vmax 16.03 µM/nM/s× 5 nM, ATP KM 0.92 µM, AMP KM 0.92 µM. For PK
the values used were: Vmax 0.68 µM/nM/s× 24000 nM, KM 3026 µM. For LDH the
values used were: Vmax 1.71 µM/nM/s × 500 nM, Pyruvate KM 142.7 µM, NADH
KM142.7 µM. The same KM was used for both PEP and ADP for the PK reaction.
A numerical solution for concentrations in the experiment was calculated for a total
time period of 2 minutes after the reaction started. Numerical solutions for ATP
concentrations corresponding to those used in the assay were calculated; 1000, 750,
500, 100, 50, 10, and 5 µM ATP.
2.7 Adenylate Kinase Evolution Experiment
Adaptation of G. stearothermophilus NUB3621-R:ThEV to higher temperature was
done in a turbidostat system with a temperature ramp of 0.2￿. Bacteria were grown
in LB supplemented with 0.59M MgSO4, 0.91M CaCl, 0.04M FeSO4, and 1.05M
NTA. 5 mg/ml rifampicin and 10 mg/ml chloramphenicol were also added to the
media. The media was prepared in 10 L batches, and cooled overnight before addition
of the supplements and the antibiotics. The vessel volume of the turbidostat was
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filled with modified LB media up to 400 ml. The turbidostat was filled and the
stirring turned on, but the temperature was system was allowed to rest overnight to
test for contamination before the temperature was increased. Glycerol stock of G.
stearothermophilus NUB3621-R:ThEV AKQ199R was plated onto modified LB plates,
with rifampicin and chloramphenicol, and grown overnight at 60￿. A single colony
was used to inoculate a 10 ml test tube with modified LB, plus rifampacin and
chloramphenicol, and grown overnight at 60￿. The vessel was inoculated with the 10
ml test tube after allowing to equilibrate to 60￿. OD was measured continuously, and
the control loop was turned on once the OD reached 0.2. Once the OD reached 0.2
the temperature was increased by 0.2￿, and the first sample was collected. Samples
were collected every 12 hours, and the OD was measured at the same time to verify
the turbidostat set-points. 50 ml 10% glycerol samples were frozen and stored in
the -80￿ to restart the fermenter run in case the fermenter run was interrupted. A
genomic DNA sample was prepared from a second 50 ml sample. A 1 ml glycerol
sample was stored in the -80￿ for use in sequencing. The temperature was increased
by 0.2￿ every 24 hours for 14 days to a final temperature of 62.4 ￿.
2.8 Derivation of Mathematical Equations
2.8.1 Derivation of Diﬀusion Equations
Diﬀusion across the membrane is governed by Fick’s law (2.10)
J = −D∆φ (2.10)
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The gradient ∆φ is the diﬀerence in concentration across the membrane for both the
outer membrane [MCNO]− 12 [MCNP ] and the inner membrane [MCNP ]− 12 [MCNC ].
Due to changes in pH the apparent concentration of MCN is 1/2 of the actual con-
centration since only certain MCN species can diﬀuse through each membrane. The
diﬀusivity −D is the permissivity of the membrane multiplied by the area of the
membrane, POAO. The diﬀusion across either membrane is therefore;
JO = DO
￿
[MCNO]− 1
2
[MCNP ]
￿
(2.11)
JI = DI
￿
[MCNP ]− 1
2
[MCNC ]
￿
(2.12)
The flux across each membrane into the periplasm per unit volume is;
JO =
POAO
VP
￿
[MCNO]− 1
2
[MCNP ]
￿
(2.13)
JI =
PIAI
VC
￿
[MCNP ]− 1
2
[MCNC ]
￿
(2.14)
At steady state the concentration inside the periplasm is constant so the flux
across the outer and inner membranes is equal; ∂[MCNO]∂t =
∂[MCNI ]
∂t .
POAO
VP
￿
[MCNO]− 1
2
[MCNP ]
￿
=
PIAI
VC
￿
[MCNP ]− 1
2
[MCNC ]
￿
(2.15)
replace PIAIVI with DI .
DO
DI
￿
[MCNO]− 1
2
[MCNP ]
￿
=
￿
[MCNP ]− 1
2
[MCNC ]
￿
DO
DI
[MCNO]− POAO
PIAI
1
2
[MCNP ] = [MCNP ]− 1
2
[MCNC ]
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DO
DI
[MCNO] +
1
2
[MCNC ] =
DO
DI
1
2
[MCNP ] + [MCNP ]
[MCNP ] =
[MCNC ]/2 +
DO
DI
[MCNO]
1 + DODI
1
2
The flux through the inner membrane is therefore
JI =
PIAI
VI
￿
[MCNC ]/2 +
DO
DI
[MCNO]
1 + DODI
1
2
− 1
2
[MCNC ]
￿
(2.16)
2.8.2 Derivation of Kinetic Equations
TetX2 catalyzes the degradation of minocycline through a random binding bisub-
strate reaction which requires NADPH and minocycline. The reaction rate Vmax can
be calculated using Michealis-Menten bisubstrate kinetics.
v =
Vmax[NADPH]
KNADPHM +[NADPH]
[MCNC ]
KMCNM [NADH]
KNADPHM +[NADPH]
+ [MCNC ]
(2.17)
Vmaxobs and KMobs can be used to simplify the bisubstrate equation.
V obsmax =
Vmax[NADPH]
KNADPHM + [NADPH]
(2.18)
KobsM =
KMCNM [NADPH]
KNADPHM + [NADPH]
(2.19)
v =
V obsmax[MCN]
KobsM + [MCN]
(2.20)
The degradation rate of minocycline in the cell is calculated by the reaction speed
of TetX2 multiplied by the concentration of TetX2 and divided by the volume of the
cell.
V =
V obsmax[TetX2][MCN]
KobsM + [MCN]
(2.21)
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2.8.3 Derivation of Minocycline Concentration
At steady state the influx of minocycline (equation 2.16) through the inner membrane
is equal to the degradation rate of TetX2 (equation 2.12);
V obsmax[TetX2][MCNC ]
KobsM + [MCNC ]
= DI
￿
[MCNP ]− 1
2
[MCNC ]
￿
(2.22)
V obsmax[TetX2][MCNC ]
KobsM + [MCNC ]
= DI
￿
[MCNP ]− 1
2
[MCNC ]
￿
V obsmax
DI
[TetX2][MCNC ]
KobsM + [MCNC ]
= [MCNP ]− 1
2
[MCNC ]
V obsmax
DI
[TetX2][MCNC ] =
￿
[MCNP ]− 1
2
[MCNC ]
￿￿
KobsM + [MCNC ]
￿
V obsmax
DI
[TetX2][MCNC ] = [MCNP ]
￿
KobsM + [MCNC ]
￿− 0.5[MCNC ]KobsM − 0.5[MCNC ]2
[MCNP ]
￿
KobsM + [MCNC ]
￿
=
V obsmax
DI
[TetX2][MCNC ] + 0.5[MCNC ]K
obs
M + 0.5[MCNC ]
2
[MCNP ]
￿
KobsM + [MCNC ]
￿
=
￿
V obsmax
DI
[TetX2] + 0.5KobsM
￿
[MCNC ] + 0.5[MCNC ]
2
[MCNP ] =
￿
V obsmax
DI
[TetX2] + 0.5KobsM
￿
[MCNC ] + 0.5[MCNC ]2
KobsM + [MCNC ]
replace [MCNP ] with equation (2.19).
[MCNC ]/2 +
DO
DI
[MCNO]
1 + 0.5DODI
=
￿
V obsmax
DI
[TetX2] + 12K
obs
M
￿
[MCNC ] + 0.5[MCNC ]2
KobsM + [MCNC ]
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replace with 1 + 0.5DODI with DP .
[MCNC ]/2 +
DO
DI
[MCNO]
DP
=
￿
V obsmax
DI
[TetX2] + 12K
obs
M
￿
[MCNC ] + 0.5[MCNC ]2
KobsM + [MCNC ]
￿
[MCNC ]/2 +
DO
DI
[MCNO]
￿￿
KobsM + [MCNC ]
￿
=
￿￿
V obsmax
DI
[TetX2] +
1
2
KobsM
￿
[MCNC ] + 0.5[MCNC ]
2
￿
DP
0.5[MCNC ]K
obs
M +
DO
DI
[MCNO]K
obs
M +
DO
DI
[MCNO][MCNC ] + 0.5[MCNC ]
2
=
￿
V obsmax
DI
[TetX2] +
1
2
KobsM
￿
[MCNC ]DP + 0.5[MCNC ]
2DP
0 = 0.5[MCNC ]K
obs
M +
DO
DI
[MCNO]K
obs
M +
DO
DI
[MCNO][MCNC ] + 0.5[MCNC ]
2
−
￿
V obsmax
DI
[TetX2] +
1
2
KobsM
￿
[MCNC ]DP − 0.5[MCNC ]2DP
0 =
DO
DI
[MCNO]K
obs
M
+
￿
DO
DI
[MCNO] + 0.5K
obs
M − 0.5DPKobsM −
DP
DI
V obsmax[TetX2]
￿
[MCNC ]
+ (1−DP ) 0.5[MCNC ]2
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0 = DO[MCNO]K
obs
M
+
￿
DO[MCNO] + (DI −DIDP )0.5KobsM −DPV obsmax[TetX2]
￿
[MCNC ]
+ (DI −DIDP ) 0.5[MCNC ]2
Replacing DP with 1 + 0.5
D0
DI
;
DI −DIDP = DI −DI
￿
1 + 0.5
DO
DI
￿
DI −DIDP =✚✚DI −✚✚DI − 0.5✚
✚DIDO
✚✚DI
DI −DIDP = 0.5DO
0 = DO[MCNO]K
obs
M
+
￿
DO[MCNO] +DO0.25K
obs
M −DPV obsmax[TetX2]
￿
[MCNC ]
+DO0.5[MCNC ]
2
Divide by DO.
0 = [MCNO]K
obs
M
+
￿
[MCNO] + 0.25K
obs
M −
DP
DO
V obsmax[TetX2]
￿
[MCNC ]
+ 0.25[MCNC ]
2
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0 = [MCNO]K
obs
M
+
￿
[MCNO] + 0.25K
obs
M −
1− 0.5DODI
DO
V obsmax[TetX2]
￿
[MCNC ]
+ 0.25[MCNC ]
2
1− 0.5DODI
DO
=
DI − 0.5DO
DODI
1− 0.5DODI
DO
=
1
DO
− 0.5 1
DI
0 = [MCNO]K
obs
M
+
￿
[MCNO] + 0.25K
obs
M −
￿
1
DO
− 0.5 1
DI
￿
V obsmax[TetX2]
￿
[MCNC ]
+ 0.25[MCNC ]
2
We can replace 1DO − 0.5 1DI with 1D since the diﬀusion constant will be a variable.
0 = [MCNO]K
obs
M +
￿
[MCNO] + 0.25K
obs
M −
V obsmax
D
[TetX2]
￿
[MCNC ]
+ 0.25[MCNC ]
2 (2.23)
Solving the quadratic equation for MCN yields;
a = −0.25
b = [MCNO]− 0.25KobsM −
V obsmax
D
[TetX2]
c = KobsM [MCNO]
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[MCNC ] = 2
￿
[MCNO]− 0.25KobsM −
V obsmax
D
[TetX2]
￿
− 2
￿￿
[MCNO]− 0.25KobsM −
V obsmax
D
[TetX2]
￿2
+KobsM [MCNO] (2.24)
GR = 1− [MCNC ]
B
A+ [MCNC ]B
(2.25)
2.9 Measuring Population Dynamics Using Next
Generation Sequencing
We used a newly developed barcoding method called FREQ-SEQ [Chubiz et al.,
2012] to generate population distribution histograms for TetX2 evolution experiments.
Genomic DNA from each the heterogenous populations was isolated from each day
of the experiment. An initial sample was taken as an initial timepoint, for a total of
31 samples covering the 10 experiments for 3 days. Genomic DNA was isolated using
a Mo Bio UltraClean Microbial DNA Isolation kit. An initial PCR step was used to
amplify the region the tetx gene is in.
Primer pair for genome amplification:
Forward: 5GAAGAAGGCGAACCTGAAAGGCTACGGCCGATAATTGGTCGCC-
CGAGAAGTAGAGGACCTAGAAGGAGAC
Reverse: 5CGGCATAATTTCTTGACGGAAGCACGAACTTTCATTTTTACTCTC-
CGTAACTTATTATACATTTAACAATTGCTG
The barcoded primers were amplified oﬀ of a plasmid derivative of pUC19 stored
in DH10B E. colicells in glycerol stocks at -80￿ (gift of C. Marx, Harvard).
Illumina barcode amplification primers:
Forward: AATGATACGGCGACCAC
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Reverse: ACTGGCCGTCGTTTTAC
Gel extraction and ethanol precipitation were used to purify the barcoded primers.
A 10% acrylamide gel was run for 30 minutes to purify the PCR solution. The
acrylamide gel was stained with a 10% ethidium bromide solution for 30 minutes. The
band containing the barcode primer was then cut out of the gel. Gel electrophoresis
was used to extract the DNA from the gel fragment. The gel fragment was placed
inside a dialysis bag, with 12,000 to 14,000 MWCO, with 300 ml of buﬀer and the bag
was placed inside the gel box antiparallel to the running direction. Electrophoresis was
run for 30 minutes to allow the barcode DNA fragment to run out of the gel fragment
into the dialysis bag. 700 ml of ethanol were added to the solution after the contents
of the dialysis bag were transferred to a 1.5 ml microcentrifuge tube. 10% ammonium
acetate was then added to the solution. The solution was incubated overnight at -
40￿. A second incubation was performed for an additional 1 hour in a dry ice ethanol
bath. The bath needs to be kept at a temperature near -50￿ to prevent the solution
from freezing. Centrifugation at 15,000 rpm in a microcentrifuge was performed for 30
minutes at 4￿ to pellet the DNA. The solution was then decanted and the precipitate
lyophilized to remove all traces of ethanol contamination. The DNA was resuspended
in 20 µl of ddH2O.
Because the read length of Illumina sequencing is only around 100 bases the
targeted base pair has to be near the start of the oligonucleotide used for barcoding.
The gene regions surrounding each of the targeted base pairs were amplified from the
product of the initial PCR reaction. The primer is also used to insert a segment of
M13 DNA that is complementary to the barcode primer M13 region.
Illumina Forward primers: K64/A161:
Forward: GTAAAACGACGGCCAGTTGGTGGAACCCTTGACCTACA
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Reverse: CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTCCAC
TTCTTCTTACCAGGTTCAAGC
F235/T674:
Forward: GTAAAACGACGGCCAGTAACCCCAATAATAATGGTGCATTGCA
Reverse: CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTCCCAATCA
TTGTTATGGGTAATGGG
T280/A808:
Forward: GTAAAACGACGGCCAGGACGAACGCTACAAAGAATTGATTC
Reverse: CAAGCAGAAGACGGCATACGAGCTCTTCCGATCCAATGCTA
TTAAATTTTCCATCGGC
S326/G947:
Forward: GTAAAACGACGGCCAGTCTTTTGCAGGGCAGGGAGTAAA
Reverse: CAAGCAGAAGACGGCATACGAGCTCTTCCGATCCAATTG
CTGAAACGTAAAGTCGGG
N371/A1082:
Forward: GTAAAACGACGGCCAGCAAAGAAGCACAAGAAGAATCAACTCAA
Reverse: CAAGCAGAAGACGGCATACGAGCTCTTCCGATCGCACAGACATA
CAAAAGATTGGC
Once the template strand and the barcode strand have been isolated the final
step is to amplify both strands together, A third set of primers is used for the final
extension reaction. The forward primer is complementary to the barcode strand,
and the reverse primer is complementary to the template strand. The template and
barcode strands contain the complementary M13 sequences to complete the extension.
The final template is purified using a PCR purification kit. The 31 samples were mixed
and then sent out for Illumina sequencing.
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Chapter 3
Identification and Characterization
of Novel Adenylate Kinase
Mutants
3.1 Introduction
Chromosomal replacement of an essential gene with a maladapted copy focuses adap-
tation on our target gene by creating an enzymatic “weak-link” with reduced function.
The “weak link” adaptation experiment is a powerful model system for exploring evo-
lution because of the strong and precise correlation of activity to fitness. Success in
the environment is strongly aﬀected by function because the enzyme is essential for
cell survival [Atkinson and Walton, 1967, Coun˜ago and Shamoo, 2005]. Selection
for mutations using the “weak link” method is precise because the system favors
mutations that restore activity and provide the greatest fitness benefits. We used a
previously created strain of G. stearothermophilus where the gene for adenylate kinase
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has been replaced with the homologue from the mesophile Bacillus subtilis [Coun˜ago
and Shamoo, 2005]. Comparisons of the activity and stability of mutations that
successfully restore AK mutants with ancestors provide insights into how fitness is
influenced by enzymatic activity. We changed the selection strength of the adaptation
experiment to find novel AK mutants that would allow us to compare the eﬀects of
selection strength on the accessible adaptive mutants.
Reducing selection strength alleviates constraints on possible adaptive pathways.
Mutations that provide a moderate increase to fitness are allowed to persist in the
population when selection is relaxed. New adaptive pathways and fitness peaks are
revealed by increasing the number of allowed mutations at each step. We reduced
the rate of temperature increase in the turbidostat to change the selection strength
during adaptation of our “weak link” strain of G. stearothermophilus .
We started the adaptation experiment with the first mutant identified, AK(BSUB)-
Q199R, to reduce the time required for the experiment. Since AK(BSUB)Q199R is fixed in
the population until the temperature reaches 60￿ we started at that temperature to
better capture the point in adaptation of adk where we see the most diversity of mu-
tants. Using a temperature ramp of 0.2￿ per day compared with the previously used
ramp of 0.5￿ altered the results of the turbidostat evolution experiment. We were
able to identify two novel mutants of AK(BSUB)Q199R during two diﬀerent adaptation
experiments. The mutants that we discovered contained combinations of mutations
that we had previously identified. These mutants were AK(BSUB)Q199R/T179I/Q16L and
AK(BSUB)Q199R/A193V/Q16L. Once new mutations were identified our goal was to char-
acterize the mutants to compare them with the mutants isolated from the previous
experiment. We developed a thermostable coupled assay to better measure the ac-
tivity of the novel mutants and compare them to previously identified mutations.
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The pyruvate kinase (PK: 2.7.1.40) and lactate dehydrogenase (LDH: 1.1.1.27)
coupled assay is a well described method for measuring activity of enzymes cat-
alyzing phosphotransferase reactions involving the generation of ADP at mesophilic
temperatures [Kornberg and Pricer Jr, 1951]. However, use of the coupled assay to
measure AK activity is limited to temperatures lower than 45￿. Many thermophilic
enzymes have very low activity at these reduced temperatures making meaningful
measurements diﬃcult. In addition, extrapolating kinetic measurements obtained
at 20 to 40￿ to much higher temperatures leads to significant propagation errors
that undermine the quality of interpretation. In the coupled assay, kinase activity
is measured indirectly by coupling the formation of ADP to the oxidation of NADH
to NAD+ (Figure 3.1) [Saint Girons et al., 1987]. To circumvent the limited range
of the assay, an end point coupled assay, using mesophilic pyruvate kinase (PK) and
L-lactate dehydrogenase (LDH), has been used previously to characterize the activity
of thermophilic kinases [Coun˜ago et al., 2008] [Glaser et al., 1992]. The phosphotrans-
ferase reaction is carried out at the desired high temperature and is then quenched at
specific time intervals. Afterwards the PK and LDH reactions are performed at 37￿.
However, unlike the continuous assay, this two-step assay is very time consuming and
relies on accurately quenching the reactions at each time point to build a reaction
curve [Pen˜a et al., 2011].
Figure 3.1: Coupled Assay for Adenylate Kinase
An often-overlooked attribute of the coupled assay, whether done in an end-point
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or continuous fashion, is the role of ATP feedback. Since the ADP used by PK
regenerates ATP, creating a positive feedback loop, appropriate conditions for the
assay are important to produce meaningful data. This is particularly true when the
assay is being used at high temperatures, where rates would be markedly higher and
the linear range of the assay accordingly worse. Interestingly, the caveats associated
with the use of this assay have not been considered previously, leading us to critically
evaluate the feedback eﬀects on the observed rates of NAD+ production.
The reaction rate curve can be measured continuously, simplifying measurement
of kinetic parameters for the target enzyme. Adenylate Kinases from Bacillus subtilis
(AK(BSUB)) that had been evolved to higher thermostability in a previously published
report were used to test the eﬃcacy of the assay [Coun˜ago et al., 2008]. Results were
compared to a previous study in the lab done by Matthew Pen˜a, in which AK(BSUB)
activity was measured with an end point assay [Pen˜a et al., 2011]. The important
role of feedback was addressed through mathematical modeling and experimental
validation.
3.2 LDHTT and PKGST have linear responses to
substrate production from 45-75￿
The activities of LDHTT and PKGST at 45, 50, 60, 70, and 75￿ were measured to
determine the working range for the high temperature coupled assay (tables 3.2 and
3.3). Although the reaction rate naturally decreases with temperature, the reaction
rates for the two enzymes remain fast enough that the limiting reaction is still the
adenylate kinase reaction. LDHTT activity decreases such that at less than 45￿,
overall activity is too low to eﬀectively measure AK activity. Conversely, PKGST
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Table 3.1: LDHTT activity at NADH Concentrations of 300 µM and 150 µM
NADH (µM) kcat (µMs-1) KM(µM) kcat/KM (s-1)
300 0.08 ± 0.00 142.7 ± 21.31 0.03 ± 0.01
150 0.09 ± 0.01 155.7 ± 57.10 0.03 ± 0.01
Table 3.2: LDHTT kinetics at 45 to 70￿
T (￿) kcat (µMs-1) KM(µM)
75￿ 0.1 ± 4.5e-3 98.3 ± 26.1
70￿ 0.1 ± 4.2e-3 121.9 ± 13.7
60￿ 0.08 ± 1.0e-3 142.7 ± 21.3
50￿ 0.03 ± 1.0e-3 217.4 ± 26.0
45￿ 0.02 ± 3.5e-3 195.8 ± 57.1
LDHTT was measured at 72.7 nM for all
reactions.
Table 3.3: PKGST kinetics at 45 to 70￿
T (￿) kcat (µMs-1) KM(µM)
75￿ 2.1 ± 6.5e-4 496 ± 360
70￿ 1.1 ± 1.0e-4 563 ± 115
60￿ 1.0 ± 4.7e-5 326 ± 43
50￿ 6.0 ± 4.0e-5 325 ± 62
45￿ 7.7 ± 8.3e-5 688 ± 151
PKGST was measured at 1.6 µM for 75￿and 8
µM for all other temperatures.
starts to precipitate at 80￿, presumably due to denaturation. The assay is therefore
best used in the range of 45 to 75￿. LDHTT was also assayed at a concentration of 150
µMNADH to compare the assay’s response to changes in initial NADH concentration.
kcat/KM were in good agreement at 150 and 300 µM NADH (table 3.1). Although
the AK reaction is limiting, there can be a lag phase in the reaction curve during
which the substrates for the two subsequent reactions accumulate, undermining the
quality of observed kinetic parameters. To minimize the lag phase, the reaction rates
of LDHTT and PKGST should exceed the maximum reaction rate of AK at least 6
fold [Easterby, 1981].
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Figure 3.2: LDHTT at 45 to 75￿ shows a
linear increase in activity with respect to
temperature above 45￿, below which LDH
activity decreases significantly. Reactions
were measured in triplicate at 340 nM for
2 minutes, and the first 6 seconds of reac-
tion time were used to measure the initial
velocity. The reaction rate curves were fit
to Michaelis-Menten kinetics.
Figure 3.3: PKGST shows a robust response
range from 45 to 60￿. While PK is still ac-
tive at 80￿, the protein aggregates at this
temperature. Reactions were measured in
triplicate at 340 nm for 2 minutes. The
first 6 seconds of reaction time were used to
measure the initial velocity. The reaction
rate curves were fit to Michaelis-Menten ki-
netics.
56
3.3 Modeling ATP feedback with a numerical sim-
ulation
ATP is not depleted in the coupled assay because it is a product of the PK reac-
tion. The reaction rate increases once ATP starts to accumulate because ATP is a
substrate of the AK reaction. A mathematical model using Michaelis-Menten kinet-
ics was used to model the substrate concentrations of ATP, AMP, ADP, pyruvate,
and NADH to predict what time period eﬀectively measures the reaction rate while
minimizing the eﬀect of ATP feedback. The reaction rates for AK cannot be mod-
eled as single substrate reactions since AMP is depleted normally and begins to limit
the reaction once ATP accumulates. The reaction rates for LDHTT were also mod-
eled using bi-substrate kinetics since pyruvate continues to be produced until ATP
is depleted. PKGST was modeled using a bi-substrate reaction because ADP concen-
tration accumulates above PEP concentration before the reaction is complete. The
concentration of ATP begins to increase significantly after more than 10 seconds at
all initial ATP concentrations. The initial reaction rate was measured from the first
6 seconds of the reaction curve to minimize the eﬀect of ATP feedback. Figure 3.4
shows the predicted changes in concentration for AMP, ATP, ADP, pyruvate, and
NADH at 1000 µM ATP and 60￿ for 0.5 nM AK(BSUB)Q199R/T179I. Experimentally
measured values of Vmax and KM for LDHTT and PKGST (tables 3.2 and 3.3) were
used for the simulation. Another concern when using this assay is the spontaneous
conversion of ATP to ADP at higher temperatures. The increased rate of hydrolysis
of ATP to ADP above 60￿ means ADP will start to accumulate, initiating the PK
and LDH reactions before the target enzyme is even added to the reaction. Addition
of ATP after temperature equilibration of the buﬀer limits hydrolysis from aﬀecting
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Figure 3.4: Mathematical simulation of concentrations of ATP, AMP, ADP, Pyruvate,
and NADH at 1000 µM ATP show that ATP concentration starts to increase after
ADP and pyruvate begin accumulating from the PK reaction. The reaction was
simulated for 2 minutes using equations 2.1, 2.2 and 2.3 to determine the best range
for measurement of kinase activity when feedback is present. We determined that
the ATP concentration does not begin to increase until after more than 10 seconds of
reaction time. Values for Vmax and KM are for AK(BSUB)Q199R/T179I from table 3.4 at
60￿ and 0.5 nM AK. Parameters for LDHTT and PKGST used values for Vmax and
KM from tables 3.2 and 3.3 at 60￿. A concentration of 0.5 µM LDHTT and 24 µM
PKGST was used to calculate the Vmax from the measured kcat in the simulation.
the reaction rate in the time frame of the experiment.
3.4 Comparison of data from the coupled and end
point methods
The activity of a thermostable mutant of AK(BSUB)Q199R/T179I was measured at 50,
55, 60, and 65￿ (table 3.4). A second thermostable mutant AK(BSUB)Q199R/G213E
was also measured at 60￿ (table 3.5). The calculated KM and kcat were compared
to values from a previous study, done using an end point coupled assay where the
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Table 3.4: AK(BSUB)Q199R/T179I kinetics at 55 to 70￿
T (￿) kcat (µMs-1) KM(µM) KobsM (µM) kcat/KM(s-1)
Coupled Assay
50￿ 8.5 ± 0.7 17.0 ± 8.3 2.4 ± 1.2 3.5 ± 1.7
55￿ 16.7 ± 0.6 10.9 ± 2.2 1.2 ± 0.2 13.8 ± 2.8
60￿ 15.3 ± 0.2 24.2 ± 2.1 0.7 ± 0.1 21.1 ± 1.8
65￿ 25.0 ± 1.6 253.1 ± 52.4 1.4 ± 0.3 18.0 ± 3.9
End Point Assay [Pen˜a et al., 2011]
55￿ 9.9 ± 0.2 16.2 ± 0.6 1.8 ± 0.2 5.5 ± 0.8
60￿ 13.7 ± 0.2 23.4 ± 0.2 0.7 ± 0.1 19.6 ± 2.8
65￿ 17.1 ± 1.2 163.8 ± 0.4 0.9 ± 0.2 19.0 ± 3.8
AK(BSUB) was measured at 5 nM for all temperatures.
AK reaction was decoupled from the PK and lactate dehydrogenase reactions [Pen˜a
et al., 2011]. The results from this previous study were used to ensure the accuracy
of the high temperature coupled assay. At increased temperatures, there is potential
for a significant loss of kinase activity due to unfolding, such that the observed KM
(KobsM ) is often markedly diﬀerent than the actual KM [Pen˜a et al., 2011]. Since
the relevant temperature dependent unfolding properties of AK(BSUB)Q199R/T179I and
AK(BSUB)Q199R/G213E are known, we are able to calculate KM from the equation K
obs
M =
KM(1 + Kunf) (table 3.4).
3.5 Conclusions
PKGST and LDHTT isolated from thermophiles can be used to measure the rate of
kinases such as AK(BSUB) by coupling the reduction of NADH to the production of
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Figure 3.5: Activity of AK(BSUB)Q199R/T179I measured with the coupled assay is in good
agreement with previous results using a more labor intensive end point assay [Pen˜a
et al., 2011]. AK(BSUB)Q199R/T179I concentration of 5 nM was used with 0.5 µM LDHTT
and 24 µMPKGST except at 45￿ where 1.0 µM LDHTT was used. AMP concentration
was 1.4 mM. Reactions were measured in triplicate at 340 nM for 2 minutes, and the
first 6 seconds of reaction time were used to measure the initial velocity. The reaction
rate curves were fit using Michealis-Menten kinetics.
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Table 3.5: Comparison of coupled assay and end point assay for AK(BSUB)Q199R/G213E
at 60￿
kcat (µMs-1) KM(µM) K
obs
M (µM kcat/KM(s
-1)
Coupled Assay 23.1 ± 0.8 0.5 ± 0.1 20.31 ± 4.0 42.6 ± 8.6
End Point Assay 11.2 ± 0.3 1.0 ± 0.2 37.5 ± 0.4 11.6 ± 2.4
ADP. This coupled assay is a fast and reliable method for measuring the biophysical
parameters of AK and similar enzymes. However, drawbacks include the accumulation
of ATP caused by feedback from the secondary PK reaction when the formation
of ADP is being assayed. However, the assay can still be used when feedback is
present as long as v0 is measured from the initial reaction rate, before ATP begins
to accumulate in significant amounts. In reactions where the ATP concentration
is saturating, feedback is not a problem and v0 can be measured from the linear
phase of the reaction curve. We have determined the required concentrations of the
secondary enzymes PKGST and LDHTT to match the expected rate of the measured
enzyme at the target temperatures. The assay works best for enzyme concentrations
that result in a Vmax of less than 200 µM/s to allow for accurate measurement of
the slope for v0. At high temperatures, this assay is superior to kinase assays that
utilize antibodies because the aﬃnity of antibodies can vary with temperature; the
coupled assay, however, is robust to small changes in secondary enzyme activity, as
long as the reaction rate for the measured enzyme remains limiting. The accuracy
of the assay is comparable to that of the end point assay previously used to measure
thermophilic AK activity. PKGST from G. stearothermophilus and LDHTT from T.
thermophilus can be used from 45 to 75￿ to measure the rate of phosphotransferase
reactions that produce ADP. LDH and PK isolated from rabbit muscle can be used
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to measure kinase activity at temperatures below 45￿, which, in combination with
our assay, allows measurement of rate constants up to 75￿. The assay was used to
measure the enzyme properties of adapted adenylate kinases isolated from evolution
experiments.
Decreasing the temperature ramp of the adaptation experiment allowed us to iso-
late novel thermostable mutants of adenylate kinase. Under strong selection [Coun˜ago
et al., 2006] requirements for keeping up with large temperature steps reduced the
possibility of creating triple mutants since mutants with moderate improvements in
fitness were not allowed to persist in the population. In the weak temperature ramp
experiment double mutants were able to persist in the environment long enough to ac-
quire tertiary mutations that benefited the fitness of the organism. However, because
of the lack of precise temperature control of the experiment and reduced selection
criteria the experiment suﬀered from being more stochastic than its predecessor. The
increased fitness benefit of combining either the A193V or T179I mutations with Q16L
can be explained by the importance placed on stability increases related to our choice
of selection. In most circumstances mutations that increase activity but decrease
stability are tolerated because natural genes tend to be buﬀered from small changes
in stability. Since the adk system relies on thermal unfolding rather than decreased
activity for selection, mutations that decrease stability will not provide a fitness ad-
vantage even if they process a modest increase in activity. This means that most
mutations that were recovered that provided a fitness advantage for G. stearother-
mophilus had both an increase in activity and an increase in stability. Since the
stability improvements had positive epistasis, having both of these mutations present
was beneficial even in the absence of changes in activity. A diﬀerent system is re-
quired to explore the eﬀects of increases in enzyme function that are not directly tied
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to increases in stability. Adaptation to antibiotic resistance provides a system where
fitness is still strongly tied to an increase in function of our target enzyme, but is not
limited to changes that provide stability as well as activity.
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Chapter 4
Building a Growth Rate Function
to Simulate the Eﬀect of TetX2
Mutants on Fitness
4.1 Introduction
One of the fundamental questions of evolution concerns the physical basis for fitness
diﬀerences between enzyme variants [Dykhuizen and Dean, 1990]. I am interested in
how changes in the physicochemical parameters of enzymes aﬀect the fitness of the
organism as a whole. I developed a growth rate function for the eﬀect of TetX2 on
reducing growth rate inhibition from minocycline, using the physicochemical proper-
ties of the enzyme, to predict the eﬀect of enzyme properties on fitness. The growth
rate function allows us to bridge the link between the physical properties of enzymes
and phenotypic changes. Using this model, I was able to predict the fitness func-
tion for TetX2 resulting from adaptive changes to enzyme properties, providing a
64
direct correlation between the cause (physicochemical changes to TetX2) and the
eﬀect (fitness). Mutants for TetX2 were obtained from both flask evolution and di-
rected evolution studies performed by Kasia Walkiewicz [Walkiewicz et al., 2012]. We
measured population histograms for the experimental evolution studies to reveal the
success or failure of the TetX2 mutants in vivo. We used experimental evolution to
validate the predictions made by my model and to provide additional insight that
would allow us to extend and improve it. The growth rate function was derived em-
pirically from studies about the mode of action of tetracycline antibiotics and their
eﬀects on growth inhibition [Thanassi et al., 1995,Argast and Beck, 1984,Argast and
Beck, 1985,Chopra and Roberts, 2001,Chopra and Shales, 1981], and the mechanism
of TetX2 action [Alekshun and Levy, 2007,Yang et al., 2004,Entsch and van Berkel,
1995]. Growth rates of TetX2 mutants were fit to kinetic measurements and used to
predict values for parameters governing the growth rate function.
4.2 Serial Dilution Adaptation of E. coli Contain-
ing tetX2 to Minocycline (MCN)
TetX2 is a monooxygenase-containing dehydrogenase that degrades tetracycline by
hydroxylation of position C11a [Yang et al., 2004]. TetX2 has activity towards many
first generation tetracyclines, such as oxytetracycline and chlortetracycline, and has
modest ability to inactivate minocycline [Yang et al., 2004]. The MIC for minocycline
for E. coli BW25113tetX2 was measured at 16 µg/ml compared with a value of 256
µg/ml for tetracycline [Yang et al., 2004]. Adaptation of TetX2 to MCN was used to
explore how incremental changes to the activity and aﬃnity towards substrates via
mutation can improve growth rate and, consequently, fitness. Adaptation of E. coli
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containing tetX2 to MCN was carried out in a serial dilution experiment over ten days
by Kasia Walkiewicz [Walkiewicz et al., 2012]. The bacteria were transferred once
a day to a fresh flask containing 50 ml LB with increasing concentration of MCN.
The MCN concentrations for each of the 10 days were: 10, 16, 24, 36, 52, 80, 120,
180, 300, and 320 µg/ml. At the end of the experiment the TetX2 mutant tetX2T280A
was fixed in the population. To isolate more mutants of TetX2 an error prone library
was built and screened at 8 µM MCN in LB agar plates. The winner of the initial
TetX2 experiment, tetX2T280A, was recovered from the error prone library along with
other novel mutants which match or increase the ability of TetX2 at degrading MCN.
Seven mutants of TetX2 were identified using the error prone library; tetX2T280A,
tetX2T280S, tetX2F235Y, tetX2K64R, tetX2S236I, tetX2N371I, and tetX2N371T.
4.3 Kinetic Measurements of TetX2
TetX2 is a monooxygenase-containing a flavin cofactor that hydroxylates tetracy-
clines, requiring NADPH as an electron donor [Yang et al., 2004]. The active form
of the enzyme is the reduced form TetX2red, which degrades minocycline through a
bisubstrate mechanism. TetX2red binds MCN in a binary complex and through a re-
action involving molecular oxygen hydroxylates MCN, inactivating the antibiotic and
oxidizing TetX2. TetX2oxd forms a binary complex with NADPH that recovers the
active form TetX2red. Although oxygen is required for the reaction, previous studies
suggest we can assume that diﬀusion and binding of oxygen is fast enough that we
can safely ignore its eﬀects on kinetics [Entsch and van Berkel, 1995]. The reaction
is therefore dependent on the Michaelis constant of TetX2 and MCN, KM(MCN), and
of TetX2 and NADPH, KM(NADPH), as well as the reaction rate kcat [Entsch and van
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Berkel, 1995].
4.4 Growth Rate Measurements of TetX2Mutants
Growth rates were measured by Christine Sun to measure the fitness advantage pro-
vided by the individual TetX2 mutants. Traditionally, fitness comparisons of an-
tibiotic containing bacteria have been done by comparing the minimum inhibitory
concentration (MIC) of drug required to prevent growth. MIC measurements can
vary depending on criteria used to judge if bacteria are growing when the antibi-
otic is bacteriostatic or when there is resistance to the antibiotic. Furthermore, MIC
measurements do not provide a precise measurement of fitness since measurements
are qualitative (growth or no growth). A better measurement of the fitness advan-
tage provided by TetX2 mutations is to measure growth rate dependence on MCN
(growth rate curve). The growth rate curve provides a quantitative comparison of
fitness between any two TetX2 mutants. Measurements of growth rates are also easily
scalable with the use of a plate reader. Measurements were done using a plate reader
over a period of 24 hours at diﬀerent minocycline concentrations. Growth rates at
exponential growth were calculated from each of the diﬀerent MCN concentration
growth curves using an R script provided by Rolf Lohaus. The R script measured
the maximal growth rate using a linear fit of the exponential growth phase. Mea-
surement of growth rates was complicated by the appearance of biphasic growth in
bacterial populations that were undergoing strong inhibition. In cases of biphasic
growth only the first linear growth regime was used, even if the second growth phase
showed faster growth. The first growth phase was chosen because it represents the
growth rate under antibiotic inhibition, while the causes of the appearance of the
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Figure 4.1: E. coli containing TetX2 were grown under minocycline inhibition and OD
measurements were taken over 24 hours. Some of the growth curves displayed biphasic
growth, with a second growth phase usually starting after 8 hours. The growth rates
at exponential phase were estimated by calculating the maximum growth rate of the
curve. In the cases where biphasic growth was observed only the first growth phase
was used. [Walkiewicz et al., 2012]
second growth phase is likely due to secondary growth eﬀects. Four possible causes
for the appearance of a secondary growth phase are: the existence of a subpopulation
of bacteria with increased growth rate that overtakes the initial population, the rise
of new mutants, degradation of the antibiotic in the media over time due to oxidation,
or transcriptional changes induced by the antibiotic. The plot of MCN vs maximal
growth rates describes the fitness change provided by each mutant in the presence of
MCN (growth rate curve) (figure 4.1).
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4.5 Mathematical Model for Mass Transfer of Minocy-
cline
To investigate the link between kinetic measurements and growth rates we have devel-
oped a growth rate function describing TetX2’s contribution to minocycline resistance.
MCN inhibits cell growth by reversibly binding to and inactivating ribosomes [Chopra
and Roberts, 2001]. TetX2 does not protect the ribosome from the eﬀects of MCN,
TetX2 instead provides a fitness benefit by reducing the steady state concentration
of MCN in the cell [Whittle et al., 2001]. Two factors need to be considered to un-
derstand the eﬀect of TetX2 at reducing MCN concentrations: the diﬀusion of MCN
from the bulk media into the cytoplasm, and the actual inactivation of intracellular
MCN by TetX2. The balance of the two components, influx of TetX2 by diﬀusion
and removal of MCN through TetX2 inactivation, provides a mass transfer equation
to estimate the concentration of MCN in the cell [Thanassi et al., 1995]. We can
model the ability of TetX2 to reduce the cytosolic concentration of MCN (MCNC)
by calculating the intracellular concentration of TetX2 and its associated kinetics.
When the MCNc of two mutants is equal, regardless of what the extracellular MCN
concentration is for each of the mutants, the two mutants will have the same growth
rate because the enzyme does not aﬀect MCN binding to the ribosome. An equation
that relates MCN concentration and growth rates by measuring the eﬀect of MCN
binding to the ribosome on inhibiting growth rates was used to complete the growth
rate function.
Diﬀusion of minocycline through the outer and inner cell membranes can be mod-
eled using Fick’s law of diﬀusion. Tetracyclines typically cross the outer membrane
through porins after binding Mg2+ (figure 4.3). The diﬀerence in the ionic potential
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between the periplasm and the media, called the Donnan potential, drives MCN into
the periplasm. Tetracycline concentration in the periplasm is estimated to be twice
that of the bulk media at equilibrium [Thanassi et al., 1995]. We have used this
same value for MCN, but it is likely that MCN diﬀusion will be slightly diﬀerent due
to it’s slightly diﬀerent pKa’s [Thanassi et al., 1995, Parolo et al., 2010]. Diﬀusion
through the inner membrane is dependent on the concentration of the uncharged
species of MCN. The pH diﬀerence between the periplasm and the cytoplasm means
the concentration of uncharged MCN is higher in the periplasm than the cytoplasm.
The eﬀective concentration in the cytoplasm is again 1/2 as much as the actual con-
centration in the periplasm. Because the concentration gradient across each of the
membranes is not 1:1 but is instead 2:1, MCN accumulates inside the cell to a con-
centration of 4:1 compared to the bulk media [Thanassi et al., 1995]. In the absence
of any other force, minocycline concentration in the cytoplasm (MCNC) would be 4
times the concentration in the media (MCNM) at steady state. However, degradation
of MCN works against diﬀusion to decrease the steady state concentration.
The activity of TetX2 is calculated by using Michaelis-Menten steady state ki-
netics. The TetX2 reaction involves a two state reaction with a “ping pong” or
bisubstrate mechanism. Studies of the similar reaction mechanism of p-hydroxy-
benzoate hydroxylate (PHBH) [Entsch and van Berkel, 1995], another flavoprotein,
show the binding rate of O2 is fast enough that it is not a rate limiting step. Oxygen
levels remain relatively constant during the experiment, further allowing us to focus
instead on the eﬀects of NADPH and MCN on reaction rates. The reaction begins
with MCN binding to the reduced form of the free enzyme to form the enzyme MCN
complex with equilibrium constant KM(MCN) (figure 4.2). The complex then reacts
rapidly with O2 allowing us to simplify the hydroxylation reaction to a pseudo first
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order reaction with reaction rate k1. Products of the reaction are the oxidized form of
the enzyme and the dissociation of the hydroxylated MCN (MCN*) (Reaction R 4.1).
Hydroxylated MCN is unstable at the pH of the cytoplasm and quickly degrades
non-enzymatically [Yang et al., 2004]. The enzyme has to be returned to the reduced
form from it’s oxidized state by the reductant NADPH to become active again. The
binary complex of the oxidized enzyme and NADPH binds with a Michaelis constant
defined as KM(NADPH). The complex then reacts with a reaction rate k2 to form the re-
duced enzyme and NADP+ (reaction R 4.2). Lineweaver-Burk plots of the substrates
NADPH and MCN reveal that both compounds compete for the same binding site, or
overlapping sites. Parallel lines in the Lineweave-Burk plots suggest that only binary
complexes are occurring, which is consistent with the “ping-pong” mechanism.
TetX2red +MCN
KM(MCN)−−−−−−￿￿ − TetX2red : MCN k1−−→
+O2
TetX2ox +MCN* (R4.1)
TetX2ox +NADPH
KM(NADPH)−−−−−−−−￿￿ − TetX2ox : NADPH k2−→ TetX2red +NADP (R4.2)
The Michaelis-Menten equation for a bisubstrate reaction is
vo =
vmax
1+
KM(B)
[B]
[A]
KM(A)
1+
KM(B)
[B]
+ [A]
(4.1)
Where MCN is substrate A and NADPH is substrate B [Cleland, 1963]. The deriva-
tion of the bisubstrate rate equation appears in section 2.8.2.
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Figure 4.2: TetX2 degradation of minocycline occurs through a “ping-pong” or binary
mechanism. The reduced form of TetX2 (TetX2red or TetX2*) reacts with minocycline
to form the hydroxylated product MCN*. NADPH reacts with TetX2 to produce the
activated form of the enzyme and NADP.
4.6 A physiological model for TetX2 mediated in-
activation of MCN
We developed a growth rate function based on experimental data to quantitatively
describe the success and failure of each adaptive mutation over a range of MCN con-
centrations from their in vitro properties (figure 4.3). As shown in figure 4.8, growth
rates for E. coli BW25113 carrying variants of tetX2 could be predicted accurately
from experimentally derived kinetics and protein expression levels. Inhibition of bac-
terial growth rates by cytosolic MCN (MCNC) was determined by fitting the growth
rate dependence of E. coli to MCN with equation 2.25.
Growth rate inhibition by MCNC is predicted to be dependent on the ratio of
uninhibited ribosomes to total ribosomes. We can assume that the growth rate of
bacteria, at exponential phase, will roughly increase linearly with free ribosome con-
centration as a proportion of total protein [Ecker and Schaechter, 1963]. Under MCN
inhibition the total fraction of available ribosomes will be equal to 1 minus the ra-
tio of inhibited, or substrate bound, ribosomes. The Hill function (equation 2.25) is
a general biochemical function for substrate binding that can be used to calculate
the fraction of uninhibited ribosomes and the fraction of ribosomes that are being
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inhibited by binding MCN. The Hill function was developed originally to provide an
empirical measurement of binding of oxygen to hemoglobin [Weiss, 1997]. The func-
tion has been extended to apply to more general measurements of ligand-receptor
interactions. In our case we can use the Hill equation to provide an empirical mea-
surement of the binding of MCN to the ribosome, as well as to the functional eﬀect
of subsequent binding events on reducing the growth rate of bacteria.
GR = 1− [MCNC ]
B
A+ [MCNC ]B
(2.25)
At steady state the concentration of NADPH and MCN will be constant, providing a
constant degradation rate of MCN to counteract diﬀusion [Thanassi et al., 1995]. In
E. coli BW25113, endogenous MCN export was assumed to be negligible compared
to degradation by TetX2 such that at steady state the rate of diﬀusion of minocycline
equals the degradation rate of MCN by TetX2 (equation 2.22).
V obsmax[TetX2][MCNC ]
KobsM + [MCNC ]
= DI
￿
[MCNP ]− 1
2
[MCNC ]
￿
(2.22)
The bisubstrate kinetics equation (equation 2.17) and Ficks law (equation 2.10) were
used to calculate the steady state cytosolic MCN (MCNC) concentration from the
concentration of MCN in the media (equation 2.24). Derivation of the steady state
equation is detailed in section 2.8.1.
[MCNC ] = 2
￿
[MCNO]− 0.25KobsM −
V obsmax
D
[TetX2]
￿
− 2
￿￿
[MCNC ]− 0.25KobsM −
V obsmax
D
[TetX2]
￿2
+KobsM [MCNC ] (2.24)
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where
V obsmax =
Vmax[NADPH]
KNADPHM + [NADPH]
(2.18)
KobsM =
KMCNM [NADPH]
KNADPHM + [NADPH]
(2.19)
We assumed that the concentration of NADPH in the cell is constant because cellular
metabolism constantly regenerates the NADPH pool, and was not likely to be altered
by addition of MCN. The NADPH concentration is therefore estimated to be 150
µM [Andersen and von Meyenburg, 1977]. The concentration of TetX2 in the cell will
also determine the degradation rate since vmax = kcat×[TetX2]. While we do not know
what the concentration of TetX2 is inside the cell we are able to measure the relative
concentrations of each mutant protein. Changes in both protein expression levels and
stability between each of the diﬀerent mutants may alter the amount of active protein
that is present in the cell. Unfortunately, we were unable to measure the temperature
dependent stability of the protein because the protein unfolds irreversibly and the
multiple transitions were observed in CD signal under thermal unfolding [Walkiewicz
et al., 2012]. However, we were able to measure the relative protein concentrations
of each of the mutants (table 4.3). The protein concentrations were calculated by
measuring the enzyme activity in cell extracts towards MCN and normalizing for
total protein, measured using a Bradford assay. These protein concentrations give
us a measure of the relative activity for each of the mutants with a given kcat. The
caveat of this measurement is that it is dependent on accurate measurements of kcat.
The relative rates of diﬀusion and enzyme catalysis in the growth rate function are
inversely proportionate since these two values are always present in the form of VmaxD
in equation 2.24. The diﬀusion parameter D is therefore more accurately described
as the ratio of diﬀusion rate to protein concentration. This value is also modified
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Table 4.3: Normalized Concentration and Total Activity for TetX2 Mutants From
Cell Extracts
Concentration* Activity (µMs-1)
TETX2 1.00 0.16
T280A 0.77 0.19
F235Y 2.00 0.22
K64R 1.14 0.14
N371I 1.36 0.27
N371T 1.44 0.25
S326I 1.56 0.24
T280S 2.03 0.16
*Concentrations were calculated using the measured
kcat and normalized to TetX2 wild type
by the fact that the diﬀusion rate scales with the surface area of the cell, while the
protein concentration instead is inversely proportional to the volume of the cell. D
is therefore a lumped parameter that accounts for the diﬀusion constant, normalized
protein concentration, and cell volume that is assumed to be constant among the
mutants. Therefore, the unknown parameters of the system are the combined diﬀusion
rate, D, and the Hill function parameters, A and B, which describe the interaction
between MCNC and growth rate. At higher concentrations of MCN, inhibition of
cell growth is a consequence of the limited ability of TetX2 or a particular variant to
inactivate MCN to tolerable levels.
The Hill function parameters, A and B, were determined by fitting the Hill func-
tion to the mutant’s experimental growth rates plotted against MCNC. Each MCNC
point was calculated from the corresponding MCNO point for each mutant by using
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equation 2.25 and the measured values of KM(MCN), KM(NADPH), and kcat(table 4.1).
The parameter A corresponds to the apparent dissociation constant KD for minocy-
cline binding to the ribosome. KD in the context of the model represents interactions
between MCN and the ribosome but is also aﬀected by other MCN interactions within
the cytosol that can compete with MCN binding to the ribosome. Despite this caveat,
the value of A was estimated to be about 26 µM, which is in good agreement with
the MCN concentration at which adaptive mutants were isolated (32 µM). The pa-
rameter B is the Hill coeﬃcient that represents how the eﬀect, on the growth rate at
exponential phase, of increasing MCN concentration deviates from a linear response.
Parameters for A, B, and the combined diﬀusion rate D were fitted using a least
squares method to find the best fit for estimating growth rates. An optimization
function was used to find the parameters that minimized the sum of squared (SS)
diﬀerence between the measured and predicted growth rate measurements.
SS =
￿
(Measured Growth Rate− Predicted Growth Rate)2 (4.2)
A mathematical transformation was used to linearize the curve to improve the
response of the model to edge eﬀects [Zarr, 1999].
(Growth Rate)transformed = arcsine(Growth Rate
2) (4.3)
The arcsin transformation stretches the edges of the model, which improves the
model’s ability to fit the edges of the curve. Growth rate curves were transformed
back after the fit was finished, so that there is no eﬀect on the final shape of the
curve. Growth rates that were higher than the normalized initial growth rate (nor-
malized to 1.0 at 0 MCN) were normalized to be equal to 1.0, since that is defined
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Figure 4.3: A) MCN flux through the cell membrane is controlled by passive diﬀusion.
The diﬀerence in Mg+2 concentration and pH across the outer and inner membranes
respectively aﬀects the concentration of species that can diﬀuse across the membrane.
We can estimate the apparent concentration of MCN in the periplasm to be 12 that of
the concentration in the media and further, that the apparent concentration of MCN
in the cytoplasm is once again 12 that of the periplasm [Thanassi et al., 1995]. B) The
rate of degradation by TetX2 is calculated using the Michaelis-Menten equation for a
bisubstrate reaction. At steady state the rate of diﬀusion is equal to the degradation
rate by TetX2. C) Solving the quadratic equation for the concentration of MCN inside
the cell results in a function that depends on the combined diﬀusion constant D and
kinetic parameters. D) The eﬀect of growth rate inhibition by MCN is calculated from
the concentration of MCN inside the cell and the variables A and B by using the Hill
equation where growth rate is proportional to the uninhibited ribosome concentration.
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as the maximal normalized growth rate of the bacteria. The mathematical fits were
done using the R programming language and the optim function with standard pa-
rameters [Ihaka and Gentleman, 1996]. The function optim finds the best value of
A, B, and D that minimizes the value of the total sum of squares (SS). The R func-
tion optim uses the Nealder-Mead algorithm for optimization. The initial guesses for
the model parameters were 20, 6, and 0.01. The predicted parameter values were:
A = 25.8, B = 2.5, D = 6.7× 10−4. The A parameter and the accumulation of MCN
inside the cytoplasm are correlated since decreasing A can roughly compensate for an
increase in MCN accumulation. We can observe the correlation between the param-
eters A and D by calculating the sum of squared diﬀerences for the surface on which
the mathematical fit occurs (figure 4.4). The surface for A and D is much flatter
than the surface for A and B or B and D. The solution occurs at the intersection of
the three two dimensional surfaces. Bacteria with significant changes to membrane
chemistry or transporters could have a diﬀerent eﬀect on the interactions of the three
parameters.
4.7 Measuring Population Distributions Using High
Throughput Sequencing
In order to test if any of the other TetX2 mutants can have success in rising in fre-
quency in the flask population, ten more sets of serial dilution adaptation experiments
were carried out by Kasia Walkiewicz [Walkiewicz et al., 2012]. These experiments
were carried out over 3 days with MCN concentrations of 10, 16, and 24 µg/ml.
Walkiewicz et a., showed that kinetic measurements and growth rate measurements
suggested that the mutants tetX2T280A, tetX2N371I, and tetX2N371T provide similar
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(a)
(b)
Figure 4.4
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(c)
Figure 4.4: Surfaces showing the sum of squared diﬀerence values between experi-
mental and model growth rate curves for diﬀerent values of A, B, D. Each of the
surfaces reveals a furrow for solutions in 2 dimensions; a) A and B, b) A and D, and
c) B and D. The fit is able to converge at the point where the three surface inter-
sect. The point represents the value at each surface where the minimum of the three
dimensional surface of A, B, and D exists.
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benefits to fitness (table 4.1, figure 4.1) [Walkiewicz et al., 2012]. Assuming that
there is no major diﬀerence in mutation rate for each of the three mutations, all three
mutations should provide suﬃcient benefit to appear in the population. We carried
out a deep sequencing experiment to build a histogram of tetX2 mutants in each
of the three experiments (figure 4.7). To measure population dynamics we used a
sequencing method that exploits the large number of short reads that are produced
by next generation sequencing technologies, specifically Illumina sequencing (FREQ-
SEQ) [Chubiz et al., 2012].
Illumina short read sequencing technology was first developed for genome sequenc-
ing but has been adapted by Chubiz et al., to monitor allelic frequencies in mixed
populations [Bentley et al., 2008,Chubiz et al., 2012]. The genome is first digested
into smaller fragments, each fragment is barcoded and the mixture is sequenced using
a multiplexed method [Bentley et al., 2008]. Illumina forward and reverse primers are
added to each of the fragments before sequencing. The forward and reverse primer
regions are complementary to oligonucleotides that are immobilized on the Illumina
flowcell surface. Fragments are amplified on the plate such that each of the fragments
occupies a distinct spot on the plate. Because each section of the flowcell surface con-
tains numerous fragments sequencing is multiplexed through reading multiple spots at
each sequencing cycle [Bentley et al., 2008]. The entire sequence is stitched together
when the overlapping fragments from each segment are used to order the individual
sequencing reads computationally. The strength of this system is the ability to read
multiple sequences simultaneously and provide a high enough read density to be able
to piece together a genome by ensuring that each fragment of DNA is read multiple
times. The coverage for an entire de novo bacterial genome is usually onf the order
of 20 to 40 times [Bentley et al., 2008].
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Figure 4.5: First the region containing the target gene is first amplified from the
chromosome. The region containing the target nucleotide is amplified oﬀ the gene
with flanking regions containing and M13 sequence in the 5’ end and the Illumina
reverse sequence on the 3’ end. The barcode sequence is amplified oﬀ a plasmid with
the Illumina forward sequence on the 5’ end and the complementary reverse M13
sequence on the 3’ end. The barcode and the target oligonucleotide are amplified
together with an Illumina forward and reverse primer to form the final oligonucleotide
for sequencing. Adapted from diagrams obtained from Lon Chubiz [Chubiz et al.,
2012].
Figure 4.6: Each of the 5 target nucleotides was amplified on a separate segment
of DNA for each day for a total of 81 fragments. The fragments were labeled with
unique 6 nucleotide barcodes that identify the day of the experiment. The primer for
each segment identifies the target nucleotide site, and the barcode identifies the day
of the experiment when the sequencing results are analyzed. Adapted from diagrams
obtained from Lon Chubiz [Chubiz et al., 2012].
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FREQ-SEQ exploits the large number of possible reads to instead repeatedly
sequence near-homogenous sequences to measure ratios of single nucleotide variation
[Chubiz et al., 2012]. Instead of having an entire genome broken into random segments
specifc oligonucleotides that includes the target region for sequencing are used to
monitor SNP and INDEL frequency. The oligonucleotide also included a 6 nucleotide
identifier sequence, or barcode, to identify the sample (a time point in the case of our
experiment, for example, day 1). The barcodes were generously donated by the Marx
Laboratory at Harvard [Chubiz et al., 2012]. Oligonucleotides containing each of the
target mutation positions were amplified and then barcoded with the corresponding
time point in separate reactions. 31 barcodes were used to identify each day of the
ten populations. There were a total of 3 time points each for days 1, 2, and 3, and an
initial starting population at day 0. Each mutation site, a808 (T280), a1082 (N371),
t674 (F235), g947 (S326), and a161 (K64), required a diﬀerent oligonucleotide. In
total there were 31 × 5 = 155 separate oligonucleotides for sequencing. Because of
the small number of individual DNA fragments compared to a standard Illumina
genome sequencing project coverage of each nucleotide increased to about 103 to
106 per nucleotide, giving us an extremely accurate measurement of the ratio of
nucleotides at each position. Sources of potential error include polymerase error
during amplification and sequencing chemistry. The distribution of A, T, G, and
C bases of positions that did not provide beneficial mutations was used to estimate
the confidence interval for identifying population distributions. We estimate that the
coverage for each oligonucleotide was on the order of 103 to 104 individual reads [Erlich
et al., 2009]. Measurement of the distribution at each position was calculated to be
within 0.5% error [Walkiewicz et al., 2012].
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Figure 4.7: Deep sequencing was used to monitor the frequencies of adaptive tetX2
variants (identified by error-prone mutagenesis) in ten individual populations of E. coli
BW25113tetX2 evolved for three days to increasing MCN concentrations (10, 16 and
24 µg/ml). The plot represents the relative frequencies of each of the 4 possible single
nucleotide replacements fore each of the 5 nucleotide positions where mutations were
found, A1082, A161, A808, G974, and T674. As predicted by the model, mutation
tetX2T280A is the most successful and is present in five (out of 10) populations, while
tetX2N371I is found in two populations and reaches fixation in one of them (Population
8). An unexpected neutral allele tetX2T280S is present in two populations. The
remaining mutants do not appear or remain at very low frequencies. The possibility of
mutations outside of tetX2 providing fitness benefits results can account for variability
of evolutionary outcomes.
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4.8 Conclusion
The growth rate function was able to accurately predict the fitness eﬀects of TetX2
adaptive mutants that were recovered using directed evolution. We were able to
accurately model the growth rates for the 8 tetX2 variants isolated from random
mutagenesis using a mathematical description of the fitness eﬀects from physical
properties of the enzyme (figure 4.8). Growth rates of tetX2F235Y, tetX2S326I, and
tetX2T280S could be predicted reliably only if the intracellular protein concentration
was increased considerately from that of wild type TetX2 (table 4.3). Measurements of
population dynamics from replicate populations of E. coli containing tetX2 provide
evidence that other adaptive mutants besides tetX2T280A can have success in the
population. TetX2N371I was equally successful compared with tetX2T280A in both the
growth rates measurements and the population distribution measurements. However,
the appearance of mutations such as tetX2T280S, which does not provide a fitness
benefit when compared to WT tetX2, reveals our fitness model is still incomplete.
The discrepancy between the predicted fitness and the apparent fitness of E. coli can
be explained in two ways; either there is an unknown fitness eﬀect that is provided
by the mutation TetX2 T280S that is not caused by a change in kinetic parameters
or protein concentration, or there is a mutation that was not present in tetX2 that
allowed those populations to rise in frequency, for example, a mutation in the promoter
region of the enzyme. The probability for mutations outside of tetX2 increasing
fitness is high since the mechanisms for antibiotic resistance are complex. There is,
however, no apparent reason for why tetX2T280S would show positive epistasis with
these mutations while other tetX2 mutants do not. An increase in the frequency of
the TetX2 T280S mutation might account for the higher appearance of the mutant,
but the mutation rate would have to be several orders of magnitudes bigger than
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Figure 4.8: A growth rate function was built to predict the eﬀect of TetX2 on reducing
the inhibition of growth rates by MCN. By transforming equation 2.25 with equation
2.24 we were able to accurately fit the measured growth rate using in vitro kinetic
parameters and estimates of protein concentration.
the mutation rate of the other mutants. Comparison of whole genome sequencing
of the unadapted and adapted strains would be the best method to determine what
mutations outside of tetX2 are aﬀecting the fitness of the organism.
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Figure 4.9: The physicochemical fitness landscape shows how changes in KM(MCN) and
enzyme activity can aﬀect growth rates at 32 µM MCN. Predicted growth rates from
measured kinetic parameters for TetX2 (black), TetX2T280A (red), TetX2N371I (or-
ange), TetX2N371T (yellow), TetX2S326I (green), TetX2F235Y (blue), TetX2K64R (pur-
ple) and TetX2T280S (magenta) are highlighted on the surface of the fitness land-
scape. [Walkiewicz et al., 2012]
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Chapter 5
Using the growth rate function to
Provide Insights into Adaptation
5.1 Introduction
We used the growth rate function to determine how the biophysical properties of
TetX2 contribute directly to fitness during selection to minocycline (MCN). The pa-
rameters for the growth rate function that were calculated through the initial fit for
A, B, and D were used to back-calculate kinetic parameters as a proof of principle
showing that the modeling process is reversible. We demonstrate that the growth rate
function can be used to estimate kinetic parameters of unknown mutants without re-
quiring extensive protein purification and kinetics assays. In vitro characterization of
enzymes remains the most accurate method for estimation of kinetic parameters. The
growth rate function allows us to rapidly estimate kinetic parameters. In practice a
small number of enzymes covering a range of kinetic measurements would be required
to populate the initial model and then with the fitted parameters we could charac-
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terize new variants without additional in vitro studies. We also investigate the error
of the growth rate function on predicting the kinetic parameters using a statistical
method. The relationship of fitness to each of the three main kinetics parameters,
KM(NADPH), KM(MCN), and Vmax is also predicted using the growth rate function.
5.2 Calculating Kinetic Parameters from Growth
Rates
To validate the accuracy of the mathematical fit, the model parameters were used to
back calculate KM(MCN) and Vmax for each of the mutants from the curve of growth
rates at exponential phase (growth rate curve). We focused on predicting KM(MCN)
and Vmax because these two parameters were shown to be more important in deter-
mining fitness values than KM(NADPH). Analysis of the eﬀect of changing the various
parameters indicates the relative importance of each of them on adaptation (table 5.1).
Increasing the Vmax or decreasing the KM(MCN) causes a significant improvement in
the growth rate curve. At 32 µg/ml MCN, for TetX2 wild type, a 10% increase in kcat
causes a 23% increase in growth rate at exponential phase. Under the same condi-
tions a 10% decrease in KM(MCN) also increases the exponential phase growth rate by
17%, but the same 10% increase in KM(NADPH) only increases the growth rate by 1%
(table 5.1). KM(MCN) has a significant eﬀect in increasing the length of the plateau of
the growth curve before which the growth rate starts to decrease significantly (figure
5.3A). Decreasing KM(NADPH) will also cause a similar eﬀect to decreasing KM(MCN),
however, to a lesser extent (figure 5.3C) since the in vivo concentration of NADPH is
well in excess of the range of MCN concentrations we used. Conversely Vmax aﬀects
the slope of the growth rate curve decay (figure 5.3B). The Vmax, or the catalytic rate,
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can be increased either by increasing the overall reaction rate kcat or by increasing
the amount of active protein in the cell. Increasing either the stability of the enzyme
or the amount of protein expression will increase Vmax by causing an increase in the
steady state concentration of TetX2.
The growth rate curves for each of the mutants was fit independently using a two-
step approach. We began by using an arcsin transformation on the growth rates to
reduce edge eﬀects. Both the measured growth rate curves and the predicted curves
were transformed using the same equation. The growth rate curves were transformed
back after the mathematical fit predictions were finished. Initial tests showed that
the model predictions depended on the initial parameter guess given to the Nelder-
Mead algorithm. Further investigation suggested that this was because the solution
landscape for many of the mutants when varying Vmax and KM(MCN) contained a
furrow that corresponded to a specific value of the ratio Vmax/KM(MCN) (figure 5.3A).
To improve our ability to find a consistent solution for the fits of kinetic parameters,
we introduced the value of activity = Vmax/KM(MCN) as a second fitting parameter.
An initial fit was then done using a wide range of starting conditions for KM(MCN)
and activity (Vmax/KM(MCN)). 50 values for each of the two variables were used with
KM(MCN) ranging from 10 to 100, and Vmax/KM(MCN) ranging from 0.001 to 0.02. The
initial conditions were chosen to exhaustively cover the biologically relevant values for
the two parameters by comparison to the measured kinetics. A total number of 2500
initial conditions were tested for each mutant. The result was a set of solutions that
share a similar Vmax/KM(MCN) but could vary in absolute values of Vmax and KM(MCN)
(figure 5.1A). As shown in figure 5.1, the shape of growth rates curves generated from
an ensemble of equal Vmax/KM(MCN) ratios of varying absolute magnitudes of Vmax
and KM(MCN) produce diﬀerent growth rate responses that can be used as the second
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Table 5.1: Eﬀect of Improving Kinetic Parameters on Growth Rates
Eﬀect of Decreasing KM(NADPH) by 10% on Growth Rate
MCN (µM)
4 32 64
TetX2 WT with KM(NADPH) = 75 0.99 0.26 0.04
TetX2 WT with KM(NADPH) = 67.5 0.99 0.26 0.04
TetX2T280A with KM(NADPH) = 18.3 1.00 0.77 0.33
TetX2T280A with KM(NADPH) = 16.5 1.00 0.77 0.33
Growth rates were calculated using the growth rate function
Eﬀect of Decreasing KM(MCN) by 10% on Growth Rate
MCN (µM)
4 32 64
TetX2 WT with KM(MCN) = 35.4 0.99 0.26 0.04
TetX2 WT with KM(MCN) = 31.9 0.99 0.30 0.05
TetX2T280A with KM(MCN) = 18.0 1.00 0.77 0.33
TetX2T280A with KM(MCN) = 16.2 1.00 0.81 0.39
Growth rates were calculated using the growth rate function
Eﬀect of Increasing Vmax by 10% on Growth Rate
MCN (µM)
4 32 64
TetX2 WT with Vmax = 0.16 0.99 0.24 0.04
TetX2 WT with Vmax = 0.18 0.99 0.31 0.06
TetX2T280A with Vmax= 0.15 1.00 0.77 0.33
TetX2T280A with Vmax= 0.16 1.00 0.81 0.4
Growth rates were calculated using the growth rate function
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stage of fitting. Analysis of the shape of the growth rate curves generated from a
fixed Vmax/KM(MCN) ratio with varying absolute vales of Vmax and KM(MCN) shows
that while there is a unique solution for each value of KM(MCN) and Vmax for a given
activity ratio, as the absolute values of KM(MCN) and Vmax increase (past KM(MCN) =
100) the function collapses asymptotically to a maximum curve (figure 5.1B). If the
growth rates of a mutant are significantly under predicted when the curve is being
fit, there is a tendency for a lack of convergence because the fitting algorithm will
continue to increase KM(MCN) without aﬀfecting the shape of the curve. The lack of
convergence means the model becomes unstable at this extreme edge. As shown in
figure 5.4 and table 5.2 the agreement on the ratio of Vmax/KM(MCN) was very good
when compared with experimentally measured values. Solutions were then sorted
by calculating the maximum slope of the experimental growth rate curve (near the
midpoint) using 5 points and comparing the slope of the set of predicted growth rate
curves at the same MCN concentration (figure 5.1C). We tried a variety of diﬀerent
methods for sorting the solutions but found that using the midpoint functioned best
by minimizing the eﬀects of errors in the fit of the initial plateau as well as the tail of
the curve by focusing on the linear part of the curve. The ratio (Vmax/KM(MCN)) of
the solution from the first set that best fits the slope of the growth rates (figure 5.1) is
used as a constraint in a second fit that is used to estimate KM(MCN) (table 5.2). The
value for Vmax was then determined using the predicted activity ratio and KM(MCN).
We did not observe a significant diﬀerence between the measured and estimated values
of Vmax/KM(MCN) (paired t-test: df = 7, p = 0.2).
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Figure 5.1: A) An initial fit is done to determine the Vmax/KM(MCN) ratio that provides
the best fit for each TetX2 mutant. Fitting with multiple starting conditions results
in a series of solutions. The fits with the lowest residuals share the same ratio. B)
The same ratio of Vmax/KM(MCN) results in a series of curves with distinct eﬀects on
predicted growth rates. C) The solution that matches the slope of the growth curve
best at the midpoint is used to determine the appropriate Vmax/KM(MCN). D) The
growth curve is fit again using the Vmax/KM(MCN) value determined in the previous
step to estimate Vmax and KM(MCN).
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Figure 5.2: Surface of sum squared diﬀerence values for the model vs the measured
growth rates at diﬀerent values for parameters KM(MCN) and Vmax/KM(MCN). The
furrow represents the value of Vmax/KM(MCN) that best fits the shape of the curve.
Blue points represent fit solutions for KM and Vmax/KM(MCN) using diﬀerent starting
values for the model algorithm.
5.3 Jackknife Method for Determining Model Vari-
ation
A statistical jackknife method was used to test the variance of the model fit for
each of the mutants. Each of the variants of TetX2 was removed from the data set
sequentially and fits of the parameters A, B, and D were calculated for the remaining
seven variants. The variance of the predicted values was measured by calculating the
mean and the standard deviation of the A, B, and D predicted values from each set
of parameters (table 5.3). With the exception of F235Y, removing any of the mutants
did not have a large eﬀect on the predicted parameters (table 5.3).
We used the parameters predicted from the jackknife method to generate a set
of predictions for kinetic parameters for all 8 adaptive mutants. The mathematical
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(a)
(b)
Figure 5.3
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(c)
Figure 5.3: Changing the kinetic parameters of TetX2 aﬀects the shape of the growth
rate curve for MCN resistance. a) Diﬀerent values of KM(MCN) were used to generate
growth rate curves while kcat and KM(NADPH) were held constant at diﬀerent values.
Decreasing KM(MCN) at diﬀerent values of kcat or KM(NADPH) causes an increase in the
initial plateau, increasing the sub inhibitory concentration of MCN for that mutant.
b) Changing kcat increases the slope of the growth rate curve but has a lesser eﬀect on
the resistance to sub-inhibitory concentrations of MCN. c) A decrease in KM(NADPH)
has a similar eﬀect as KM(MCN) but to a much lesser degree. KM(NADPH) therefore has
a lesser adaptive role in increasing or decreasing the fitness of the organism.
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Figure 5.4: A growth rate function built to predict the eﬀect of TetX2 on reducing
the inhibition of growth rates by MCN (solid line) was used to predict KM(MCN) and
Vmax for each of the mutants from the measured growth rates (dashed line). We were
able to correctly back-calculate the kinetic parameters using our model for each of
the mutants (table 5.2).
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Table 5.3: Error estimates of Model Fits
A* B* D* SS**
All Mutants 25.8 2.5 6.7×10−4 1.842
TetX2 57.5 2.3 9.6×10−4 0.173
T280A 40.1 2.2 9.5×10−4 0.346
N371I 51.5 2.4 9.0×10−4 0.024
N371T 71.4 2.3 10.0×10−4 0.052
S326I 21.8 2.6 6.1×10−4 0.095
F235Y 0.1 3.2 1.2×10−4 0.509
K64R 50.3 2.3 8.9×10−4 0.105
T280S 37.2 2.4 7.3×10−4 0.538
Average 41.2 2.5 7.7×10−4
SD 22.2 0.3 2.9×10−4
* Error estimates when removing each mutant were
done using a Jackknife estimator approach.
** Sum of squared residuals (SS) were measured for
each of the individual curves from the mathematical
fit using all 8 mutants.
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fits for kinetics values of 7 out of the 8 mutants were able to converge to similar
values predicted from the parameters of the full fit. The results for predictions of
parameters for N371I are shown in table 5.4 as a representative set, with the rest
of the predictions in appendix C. However, removing F235Y from the mathematical
fit for the parameters causes a failure of the model to successfully converge when
predicting the values for F235Y, N371I, and S326I. The model under-predicts growth
rates for those mutants, causing the kinetic parameter predictions to fall into the
regime where the fit is unable to converge. The mutant F235Y does not show an
apparent diﬀerence in the shape of the growth rate curve, however, F235Y has a
significantly higher KM(MCN) than the other seven mutants as shown in table 4.1.
Analysis of the kinetic parameters reveals that we can sort the rest of the adaptive
mutants into similar patterns. We theorize that the fit of the growth rate function
requires mutants that fall into distinct categories to constrain the model in some form.
Adaptive mutants that have growth rate curves or kinetic parameters that fall outside
of the range of the original 8 mutants could therefore be very useful in increasing the
accuracy of the model.
For five of the seven mutants the growth rate and fitness eﬀects are accounted for
largely by kinetic parameters as shown in table 5.2. The experimental data at the
lowest values of KM(MCN) may be overestimated because it is diﬃcult to experimen-
tally estimate KM(MCN) when values are less than 20 µM. The model fit for TetX2
growth rates is most sensitive to KM(MCN) and is not as sensitive to KM(NADPH) at the
concentrations of MCN where our adaptation experiment occurs. KM(MCN) aﬀects
the initial plateau where there is little eﬀect on growth rate when increasing MCN.
The measured kcat values were similar for seven of the eight variants and therefore
played a lesser role in determining fitness. The total activity aﬀects the slope of the
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Table 5.4: Estimate of kinetic parameters for tetX2N371I using jackknife method model
parameters
KM(MCN) Vmax Vmax/KM(MCN)
Variant Removed* (µM) (s-1) (µM -1 s-1)
TetX2 29.61 0.4 0.014
T280A 32.11 0.46 0.014
F235Y 3.93×106 5.68×104 0.014
K64R 41.38 0.53 0.013
N371I 60.93 0.77 0.013
N371T 36.07 0.5 0.014
S326I 53.34 0.72 0.013
T280S 50.17 0.61 0.012
*Variant removed when calculating growth rate function
parameters A, B, and D.
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curve defining how severely the growth rate decreases in response to increasing MCN.
The model cannot discriminate between changes in kcat or changes in active protein
concentration since these two variables aﬀect the shape of the growth curve in the
same way. Thus the value that is best estimated by the model from growth rates
alone is for Vmax/KM(MCN). Using growth rates alone, the model is able to robustly
estimate Vmax/KM(MCN) which, in turn, can be used to estimate KM(MCN) and Vmax.
The MCN concentration where the most successful adaptive mutant (TetX2T280A) was
first observed by experimental evolution (32 µM) is very near the range of KM(MCN)s
for the most successful adaptive TetX2 mutants identified in vitro (table 4.1).
5.4 Using a Novel Mutant to Validate the Growth
Rate Function
A new double mutant of TetX2, TetX2T280A/N371D was identified from a second random
mutagenesis experiment by Anisha Perez. The growth rates and kinetics parameters
were measured by Anisha Perez, and we used the growth rate function with the
parameter predictions from the first 8 mutants to compare the predictions of KM(MCN)
and Vmaxto measured values. We were able to accurately predict the KM(MCN) for the
mutant (table 5.5). Without a measurement of protein concentration from the whole
cell extract we do not know what the Vmax is for this enzyme. However, we can predict
what the protein concentration would have to be to match our predicted Vmax to the
measured kcat. We predict that the protein concentration would have to be between
1.5 and 2.0 times the wild type concentration, which is comparable to some of the
higher protein concentration mutants from the initial 8 mutants isolated.
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Table 5.5: TetX2T280A/N371S Measured and Predicted Kinetic Parameters
Vmax kcat KM(NADPH) KM(MCN) Vmax/KM(MCN)
(s-1) (s-1) (µM) (µM) (µM -1 s-1)
measured NA 0.94 165.7 47.86 NA
predicted 0.69 NA NA 67.7 0.01
NA = values not measured
5.5 Conclusions
We were able to reliably predict the growth rates for E. coli containing tetX2T280A,
tetX2N371I, tetX2N371T, and tetX2K64R largely from the kinetic parameters. The
growth rates show a strong dependence on KM(MCN) and Vmax and a lesser eﬀect
from KM(NADPH). As expected from the range of selection for MCN and bisubstrate
kinetics, the fit for growth rates of E. coli with tetX2 is most sensitive to KM for
MCN and is not as sensitive to KM for NADPH under these selection conditions.
The combination of KM(MCN) and kcat determine the shape of the growth rate curves
with the initial plateaus being particularly sensitive to KM(MCN). The total activity
aﬀects the slope of the curve defining how severe the drop oﬀ in growth rate is to
increasing MCN. Since increasing kcat has the same eﬀect on fitness as increasing
TetX2 concentration in our model, the parameters are linked in how they aﬀect the
shape of the growth rate curve. The model cannot discriminate between changes in
kcat or changes in active protein concentration since these variables only appear in
combination with one another in the model, and therefore have the same eﬀect on
the shape of the growth rate curve. Fitness functions were determined for KM(MCN)
and Vmax using the growth rate function for the MCN concentration range of the
adaptation experiment. The fitness function allows us to make predictions about the
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eﬀects of mutations that alter kinetic parameters on the fitness of the organism. The
growth rate function correctly predicts the correlation between mutations that de-
crease KM(MCN) and the most successful adaptive mutants, tetX2T280A and tetX2N371I
in the range of the experimental evolution experiment (20 to 32 µM MCN). In popu-
lation histograms of the MCN adaptation experiments the two mutations tetX2T280A
and tetX2N371I also appear with the highest frequency, illustrating the usefulness of
the model on predicting evolutionary outcomes. The growth rate function can also be
used to make fast and reliable predictions of enzyme kinetic parameters. Once we have
determine the model parameters from a test set of enzyme kinetics and growth rates,
the model can be used to reliably predict Vmax/KM(MCN), and to predict KM(MCN) and
Vmax/KM(MCN) with reasonable accuracy.
Improvements on the growth rate function can increase the accuracy of predictions
on kinetic parameters and growth rates. Improvements on the accuracy of measure-
ment of growth rates and enzyme kinetics can improve the sensitivity of the model and
possibly allow us to predict the eﬀect of variables that have a smaller eﬀect on fitness,
such as KM(NADPH). The growth rate function can also benefit from a better under-
standing of the eﬀect of the in vitro stability of TetX2 on the concentration of TetX2
in the cell at steady state. Two factors that can have a smaller eﬀect on modeling the
fitness of TetX2 mutants are the fitness costs of producing TetX2 and the eﬀect of
regulation on TetX2 concentration. TetX2 was inserted in the chromosome in the spc
operon between prlA (SecY) and rmpJ (L36), which is tightly regulated, reducing
the possibility of regulatory changes on increasing TetX2 concentration. However,
mutations in regulatory regions are still possible sources of increased MCN resistance
using TetX2 and cannot be easily discounted. The diﬀerence in steady state concen-
trations between TetX2 mutants is suﬃcient to cause an increase in the fitness cost of
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producing the enzyme. However, since selection for mutants with increased resistance
is very strong in this experiment, mutations that enhance antibiotic resistance will be
strongly favored regardless of associated fitness costs, and the experiment does not
last long enough for compensatory mutations to arise. The growth rate function can
therefore still be improved by investigating the eﬀect on the growth rate equation of
both the fitness cost of protein production and the eﬀect of regulation on protein con-
centrations. The growth rate function can also be improved by expanding the model
to take into account other mechanisms of antibiotic resistance, as well as generalizing
the model to function for other bacteriostatic antibiotics.
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Chapter 6
Conclusions and Future Work
6.1 Discussion
The role of biophysical properties on determining evolutionary outcomes was inves-
tigated using two separate evolution experiments. Reducing the temperature ramp
allowed us to observe the rise of triple mutants of adenylate kinase that provide
increased activity by improving thermostability. The lack of novel mutation sites
in adenylate kinase adaptation under weak selection compared with strong selec-
tion suggests that the adaptive landscape for adenylate kinase under our selection
conditions is strongly constrained. Relief of selective pressure from the reduced tem-
perature ramp should have lead to the appearance of novel mutations with small or
near neutral eﬀects on fitness. Instead we observed that possible adaptive mutants
were limited to mutations that had been previously identified under strong selection,
indicating that the adaptive landscape is much smaller than we had predicted. Nega-
tive epistasis between mutations A193V and T179I with Q16L is consistent with the
theory of diminishing returns epistasis, since as the cell approaches a fitness peak,
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further increases in stability provide diminishing returns on fitness [Chou et al., 2011].
The stochasticity of the weak selection experiment is also consistent with the expec-
tation that reduced selection strength increases the eﬀect of drift on evolutionary
outcomes [Barrett et al., 2006]. However, the temperature ramp of 0.2￿ per day,
while significantly weaker than the previously used ramp of 0.5￿ per day, might be
in more of a medium selection strength regime as opposed to a truly weak selection
strength regime. However, the temperature ramp of 0.2￿ per day, while significantly
weaker than the previously used ramp of 0.5￿ per day, might not be weak enough
to allow neutral or near neutral mutations to aﬀect the outcome of the evolution
experiment significantly. Technical limitations on controlling temperature variation
in the vessel prevent us from using a weaker temperature ramp, but if we were able
to reduce the temperature ramp the eﬀects of drift can become significantly stronger,
and can allow for increased exploration of the adaptive landscape by the bacterial
population during adaptation.
The growth rate function relating enzyme properties to growth rates is able to
provide a direct link between physicochemical changes and fitness. We were able to
create a model that can predict fitness benefits from physicochemical properties of
enzymes and conversely, can predict enzyme properties from growth rates measure-
ments. The model is also able to predict numerical values for fitness changes from
changes to enzyme properties. Surprisingly the benefit from decreasing the Michaelis
constant KM for NADPH does not have a strong eﬀect on fitness outcomes compared
with KM for MCN under normal cell conditions. Strong regulation of NADPH con-
centration by cellular metabolism, and the already low KM for NADPH of wild type
TetX2 compared with the cellular concentration, might suggest why there is little
benefit to be gained from decreasing KM(NADPH). Although changes in KM(NADPH)
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were observed, there is no clear correlation between successful mutants and decreased
KM(NADPH), suggesting that the fitness prediction of the model is correct. If there
was a decrease in KM(NADPH) in response to MCN inhibition, such that enzyme eﬃ-
ciency was aﬀected, the fitness benefit of decreasing KM(NADPH) would be expected to
increase, leading to adaptive mutants with increased aﬃnity for NADPH. One of the
limitations of the present model is the failure to consider the cost of enzyme produc-
tion on fitness [Lenski, 1998], however, since the model is still accurate without this
added constraint the fitness cost of producing antibiotic resistance enzymes probably
does not play a strong role in determining fitness under the very strong antibiotic in-
hibition of growth rates of our experiment. If selection strength is decreased, there is
a probability that fitness costs of producing these enzymes can become more relevant.
However, under our model, both increasing enzyme activity and increasing enzyme
concentration provide equivalent fitness benefits, and their eﬀect on enzyme rate is
multiplicative.
The accurate prediction of the Vmax/KM(MCN) ratio using the growth rate function
provides a very useful and high-throughput method for determining enzyme proper-
ties from growth rates studies. Calculation of kinetic parameters from flux model
analysis removes the requirement for protein purification, which can be expensive in
both time and eﬀort. A set of source growth rates and enzyme kinetic measurements
with distinct properties is still required to provide an initial model. Once the initial
fit is populated, enzyme properties can be predicted, using only information of growth
rates, to quickly identify mutants with interesting enzyme properties. Candidate en-
zymes that are predicted to have improved enzyme eﬃciency can then be isolated and
purified for more in-depth measurements of enzyme kinetics. The model we have de-
veloped can be used with other enzymes that degrade bacteriostatic antibiotics. The
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model can also be used with enzymes that provide antibiotic resistance through other
mechanisms, or combinations of enzymes, by expanding the mathematical equation
used to predict the steady state MCNC concentration.
6.2 FutureWork: Extending the Growth Rate Func-
tion to Enzyme Pathways
We are interested in extending our model to mulit-enzyme systems by developing a
more general equation for the mathematical modeling of growth rates. Of the two
other major antibiotic resistance mechanisms, eﬄux pumps are a compelling target
for extending the model. Antibiotic resistance through eﬄux pumps is the most
common form of antibiotic resistance in multi drug resistant bacteria, so creating
a model that can allow us to easily compare enzyme parameters without extensive
purification would be useful in clinical applications. Eﬄux pumps work in parallel
to enzymatic inactivation to reduce the concentration of cytosolic antibiotic. A suit-
able target for implementing in the mathematical model is the eﬄux pump adeABC
from Acinetobacter baumannii, which confers resistance to the tetracycline derivative
tigecycline [Peleg et al., 2007]. The mathematical model described in Thanassi et
al., [Thanassi et al., 1995] also provides a useful mathematical equation for the ki-
netics of an eﬄux pump. We can use Michaelis-Menten to model the kinetics of the
pump in the same manner as for TetX2. Diﬀusion and accumulation of antibiotic in
the cell is unchanged since the eﬄux pump adeABC pumps antibiotic directly into
the media, bypassing the periplasm. The steady state concentration of antibiotic in
the cytoplasm can be calculated by setting the diﬀusion rate equal to the sum of the
eﬀects of the pump and the inactivating enzyme. Growth rates can be calculated
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by using the Hill equation (2.25). The parameters A, B, and D describe interactions
between the antibiotic and the ribosome and so are independent of the action of the
pump and the inactivating enzyme. Values for A, B, and D determined using the
current model are directly applicable if the same bacterial system is extended by the
addition of an eﬄux pump.
6.3 Conclusions
The biophysical and physicochemical properties of enzymes determining fitness out-
comes were explored using a combination of experimental evolution and biophysi-
cal studies. The integration of top down adaptation experiments with bottom up
biophysical studies is necessary to allow a complete understanding of mechanisms
that drive fitness diﬀerences and adaptation. Evolution experiments can provide a
source for enzyme variety needed to investigate the link between physical changes
and fitness, but more importantly, allow us to control the environment under which
evolution occurs. Control of selection conditions allows us to correlate evolutionary
outcomes to specific environmental changes. Accurate predictions of evolutionary
outcomes of adaptation experiments from biophysical measurements relies on both
correlating physicochemical changes to fitness outcomes, and knowledge of the shape
of the adaptive landscape under which fitness diﬀerences are acted on. The devel-
opment of growth rate functions based on flux analysis provides a good example of
how metabolic flux can be used to predict fitness benefits. The canonical use of
flux balance analysis is to predict growth rates from flux of a limiting resource, but
we can also use the same type of analysis to derive a growth rate function based
on antibiotic inhibition of growth rates. Evolution experiments also reveal the com-
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plexity of evolutionary outcomes, which rely on stochastic processes and epistatic
interactions that are not necessarily predicted from measurements of enzyme kinetic
properties. Improvements on measurements of kinetic properties and growth rates,
coupled with high throughput sequencing methods for determine population distri-
butions of adaptation experiments, will allow us to refine models of the mechanisms
that drive adaptation. The relationship between physical properties and fitness can
be used to predict the eﬀect of novel mutations that confer antibiotic resistance, as
well as understanding the actual physiochemical properties that provide resistance.
Coupled with structural and functional studies of mutant enzymes we can approach
a more complete understanding of the pathway from structural changes in enzymes
to phenotypic changes of organisms.
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Model Output Figures
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Figure A.1: Solutions from the first step of the mathematical modeling for all 9
mutants, including the T280A/N371S double mutant (labeled T280D)
Figure A.2: The eﬀect of varying KM(MCN) with a constant Vmax/KM(MCN) determined
by the first step of the enzyme parameter fit on growth rate curves.
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Appendix B
MATLAB and R Scripts
B.1 MATLAB script for modeling coupled assay
The MATLAB script that was used to model the coupled assay is presented here
verbatim.
1 f unc t i on [ATP,AMP,ADP,PEP,PYR,NADH] = CoupAssayBi PKbisubstrate (ATP,AMP,
ADP,PEP,PYR,NADH,AK Vmax,ATP Km,AMPKm,PK Vmax,PK Km,LDH Vmax,PYR Km
,NADHKm, n , l )
3 time = 0 ;
5 % Michae l i s Menten Equations f o r AK, PK, LDH r e a c t i o n s assuming s i n g l e
sub s t r a t e k i n e t i c s
% f o r AK v = vmax∗ [ATP] ∗ [AMP] / (KmATP∗KmAMP+KmAMP∗ [ATP]+KmATP∗ [AMP] )
7 f unc t i on [dATP] = AK(ATP,AMP,AK Vmax,ATP Km,AMPKm)
dATP = (AK Vmax∗ATP∗AMP) /(ATPKm∗AMPKm+AMPKm∗ATP+ATPKm∗AMP) ;
9 end
11 % fo r PK v = vmax∗ [ADP] ∗ [PEP] / (Km PEP∗KmADP+Km PEP∗ [ADP]+Km PEP∗ [ADP] )
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f unc t i on [dADP] = PK(ADP,PEP,PK Vmax,PK Km)
13 dADP = (PK Vmax∗ADP∗PEP) /(PK Km∗PKKm+PKKm∗PEP+PKKm∗ADP) ;
end
15
% fo r LDH v = vmax∗ [ Pyruvate ] ∗ [NADH] / ( Km Pyruvate∗KmNADH+Km Pyruvate ∗ [
NADH]+KmNADH∗ [ Pyruvate ] )
17 f unc t i on [dPYR] = LDH(PYR,NADH,LDH Vmax,PYR Km,NADHKm)
dPYR = (LDH Vmax∗PYR∗NADH) /(PYRKm∗NADHKm+NADHKm∗PYR+PYRKm∗NADH) ;
19 end
21 % Euler equat ion used to c a l c u l a t e the concent ra t i on o f ATP, ADP,
Pyruvate , and NADH
% fo r time l with step s i z e n
23 f o r i = 1 : ( l ∗n)
% Change o f ATP concent ra t i on i s equal to − r a t e o f AK + rat e o f PK
25 ATP( i +1) = ATP( i ) − 1/n∗AK(ATP( i ) ,AMP( i ) ,AK Vmax,ATP Km,AMPKm) +
1/n∗PK(ADP( i ) ,PEP( i ) ,PK Vmax,PK Km) ;
% Change o f AMP concent ra t i on i s equal to − r a t e o f AK
27 AMP( i +1) = AMP( i ) − 1/n∗AK(ATP( i ) ,AMP( i ) ,AK Vmax,ATP Km,AMPKm) ;
% Change o f ADP concent ra t i on i s equal to + 2x ra t e o f AK − r a t e o f PK
29 ADP( i +1) = ADP( i ) + 2∗1/n∗AK(ATP( i ) ,AMP( i ) ,AK Vmax,ATP Km,AMPKm) −
1/n∗PK(ADP( i ) ,PEP( i ) ,PK Vmax,PK Km) ;
% Change o f PEP concent ra t i on i s equal to − r a t e o f PK
31 PEP( i +1) = PEP( i ) − 1/n∗PK(ADP( i ) ,PEP( i ) ,PK Vmax,PK Km) ;
% Change o f Pyruvate concent ra t i on i s equal to + ra t e o f PK − r a t e o f
LDH
33 PYR( i +1) = PYR( i ) + 1/n∗PK(ADP( i ) ,PEP( i ) ,PK Vmax,PK Km) − 1/n∗LDH(
PYR( i ) ,NADH( i ) ,LDH Vmax,PYR Km,NADHKm) ;
% Change o f NADH concent ra t i on i s equal to − r a t e o f LDH
35 NADH( i +1) = NADH( i ) − 1/n∗LDH(PYR( i ) ,NADH( i ) ,LDH Vmax,PYR Km,
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NADHKm) ;
% time va r i ab l e f o r x ax i s
37 time ( i +1) = time ( i )+1/n ;
end
39 end
func t i on [ ] = ALLconc 2 (ATP,AMP,ADP,PEP,PYR,NADH,AK Vmax,ATP Km,AMPKm,
PK Vmax,PK Km,LDH Vmax,PYR Km,NADHKm, n , l )
41
% Set time vec to r f o r graph
43 time = ( 1 : ( l ∗n+1) ) / l ;
45 % Calcu la t e concent ra t i on f o r a l l 6 s ub s t r a t e s in the coupled assay
[ ATPrate AMPrate ADPrate PEPrate PYRrate NADHrate ] =
CoupAssayBi PKbisubstrate (ATP,AMP,ADP,PEP,PYR,NADH,AK Vmax,ATP Km,
AMPKm,PK Vmax,PK Km,LDH Vmax,PYR Km,NADHKm, l , n ) ;
47
% Plot o f a l l 6 s ub s t r a t e s
49 p lo t ( time , ATPrate , time , AMPrate , time , ADPrate , time , PEPrate , time , PYRrate ,
time ,NADHrate)
ax i s ( [ 0 n 0 1000 ] )
51 l egend ( ’ATP’ , ’AMP’ , ’ADP’ , ’PEP ’ , ’PYR’ , ’NADH’ )
t i t l e ( ’ Subs t ra t e s f o r Coupled Assay ’ )
53 x l ab e l ( ’Time (min ) ’ )
y l ab e l ( ’ [C] (uM) ’ )
55 end
57 f unc t i on [ ] = NADHconc 2(ATP,AMP,ADP,PEP,PYR,NADH,AK Vmax,ATP Km,AMPKm,
PK Vmax,PK Km,LDH Vmax,PYR Km,NADHKm, n , l )
59 % Set number o f i n i t i a l ATP concen t ra t i on s f o r c a l c u a t i on s
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l l = s i z e (ATP) ;
61 % Set time vec to r f o r graph
time = ( 1 : ( l ∗n+1) ) / l ;
63
% Loop f o r a l l i n i t i a l ATP concen t r a t i on s
65 f o r i = 1 : l l ( 1 , 2 )
% Calcu la t e ATP and NADH concen t r a t i on s f o r each i n i t i a l ATP
concen t ra t i on s
67 [ ATPrate i , ˜ , ˜ , ˜ , ˜ , NADHrate i ] = CoupAssayBi PKbisubstrate (
ATP(1 , i ) ,AMP,ADP,PEP,PYR,NADH,AK Vmax,ATP Km,AMPKm,PK Vmax,
PK Km,LDH Vmax,PYR Km,NADHKm, l , n ) ;
% Concatenate each vec to r f o r [NADH] and [ATP] in to one matrix f o r each
69 ATPrate ( i , : ) = ATPrate i ;
NADHrate( i , : ) = NADHrate i ;
71 end
73 % Plot s o f NADH concent ra t i on at each i n i t i a l ATP concen t r a t i on s
f i g u r e
75 p lo t ( time ,NADHrate)
ax i s ( [ 0 n 0 max(NADH) ] )
77 t i t l e ( ’ [NADH] ra t e vs [ATP] ’ )
l egend ( ’ 1000 uM’ , ’ 750 uM’ , ’ 500 uM’ , ’ 100 uM’ , ’ 50 uM’ , ’ 10 uM’ , ’ 5 uM’ )
79 x l ab e l ( ’Time (min ) ’ )
y l ab e l ( ’ [NADH] (uM) ’ )
81
% Plot s o f ATP concent ra t i on at each i n i t i a l ATP concen t r a t i on s
83 f i g u r e
p l o t ( time , ATPrate )
85 ax i s ( [ 0 n 0 max(ATP) ] )
t i t l e ( ’ [ATP] ra t e vs [ATP] ’ )
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87 l egend ( ’ 1000 uM’ , ’ 750 uM’ , ’ 500 uM’ , ’ 100 uM’ , ’ 50 uM’ , ’ 10 uM’ , ’ 5 uM’ )
x l ab e l ( ’Time (min ) ’ )
89 y l ab e l ( ’ [ATP] (uM) ’ )
91 end
93
f unc t i on [ ] = CoupledAssay 2 ( )
95
% Set the time va r i ab l e (n) in minutes and the number o f c y c l e s ( l )
97 n = 2 ;
l = 1000 ;
99
% Set i n i t i a l c oncen t ra t i on s as we l l as Km and Vmax va r i a b l e s
101 ATP 0 = [1000 750 500 100 50 10 5 ] ;
AMP 0 = 1400 ;
103 ADP 0 = 0 ;
PEP 0 = 2000 ;
105 PYR 0 = 0 ;
NADH 0 = 300 ;
107 AK Vmax = 16 . 03∗5 ;
ATPKm = 0 . 9 2 ;
109 AMPKm = 0 . 9 2 ;
PK Vmax = 0.68∗24000 ;
111 PKKm = 3026 ;
LDH Vmax= 1 .71∗500 ;
113 PYRKm = 142 . 7 ;
NADHKm = 142 . 7 ;
115
137
117 % Plot o f a l l 6 s ub s t r a t e s at 1 i n i t i a l ATP concent ra t i on
f i g u r e
119 ALLconc 2 (ATP 0(1) ,AMP 0,ADP 0 , PEP 0 ,PYR 0 ,NADH 0,AK Vmax,ATP Km,AMPKm,
PK Vmax,PK Km,LDH Vmax,PYR Km,NADHKm, n , l ) ;
121 % Plot s o f ATP and NADH concen t ra t i on s at a l l i n i t i a l ATP concen t ra t i on s
NADHconc 2(ATP 0 ,AMP 0,ADP 0 , PEP 0 ,PYR 0 ,NADH 0,AK Vmax,ATP Km,AMPKm,
PK Vmax,PK Km,LDH Vmax,PYR Km,NADHKm, n , l ) ;
Listing B.1: Coupled Assay MATLAB code
B.2 R scripts for Growth Rate Functions
The following R script was used to fit the growth rate function parameters A, B, and
D from growth rate and enzyme kinetic measurements of the original 7 mutants and
WT TetX2, and produce predictions of KM(MCN) and Vmax/KM(MCN) of the 9 TetX2
variants we have identified. A second R script was used to estimate variability of
the growth rate function predictions using the Jackknife method, and is presented in
appendix B.3.
rm( l i s t=l s ( ) )
2 #Read data f o r growth r a t e s and enzyme k i n e t i c s .
g r a t e s = read . t ab l e ( ’ GrowthRates Norm3−2. txt ’ , header = TRUE)
4 k i n e t i c s = read . t ab l e ( ’TetX2 k i n e t i c s 3 . txt ’ , header = TRUE)
run = ’B ’
6
#Set up va r i a b l e s and cons tant s .
8 bgr = gra t e s [ , 1 0 ]
min = gra t e s [ , 1 ]
10 #Kine t i c s cons tant s .
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kcat = k i n e t i c s [ , 3 ]
12 t e tx = k i n e t i c s [ , 5 ] / k i n e t i c s [ , 3 ]
knadph = k i n e t i c s [ , 2 ]
14 kmin = k i n e t i c s [ , 1 ]
grmax = 1 .0
16 #Growth ra t e data .
x1 = gra t e s [ , 1 ]
18 y2 = gra t e s [ , 2 : 1 0 ]
#Arcs ine transform the growth ra t e data .
20 y1 = as in ( ( g r a t e s [ , 2 : 1 0 ] ) ˆ0 . 5 )
y1 [ i s . nan ( y1 ) ] = as in (1 )
22 #Set g l oba l cons tant s f o r NADPH concent ra t i on and the pred i c t ed
accumulation o f MCN in s i d e the c e l l
nadph = 150
24 alpha = 4
26 #De f i n i t i o n o f the growth ra t e curve us ing a H i l l equat ion ; f unc t i on i s
the growth ra t e dependent on MCN in s i d e the c e l l , c a l c u l a t ed as
e i t h e r the a r c s i n transformed or the untrasnformed data .
MinGrowth = func t i on ( pargr , min ) { as in ((1−1/(1+pargr [ 1 ] /minˆ pargr [ 2 ] ) )
ˆ0 . 5 ) }
28 MinGrowth as in2 = func t i on ( pargr , min ){1−1/(1+pargr [ 1 ] /minˆ pargr [ 2 ] ) }
30 #Set up equat ions f o r c a l c u l a t i n g MCN concent ra t i on i n s i d e the c e l l .
#Equations f o r KM( obs ) , and Vmax( obs ) us ing e i t h e r the product o f kcat
and te tx concent ra t i on or a s i n g l e r e a c t i on v e l o c i t y .
32 TetX Vmax = func t i on (D, kcat , tetx , knadph , nadph ) {( kcat ∗ t e tx /D) /(1+knadph/
nadph ) }
TetX Vmax 2 = func t i on (D, kcat , knadph , nadph ) {( kcat /D) /(1+knadph/nadph ) }
34 TetX kM = func t i on (kmin , knadph , nadph ) {kmin/(1+knadph/nadph ) }
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#Quadratic equat ion f o r c y t o s o l i c MCN concent ra t i on f o r e i t h e r a vec to r
or s c a l a r c a l c u l a t i o n .
36 MIN Free = func t i on (a , b , c ){(−b−(bˆ2−4∗a∗c ) ˆ0 . 5 ) / (2 ∗a ) }
MIN Free2 = func t i on (vmax ,km, min0 , alpha ) {(−(min0−km/alpha−vmax)−((min0−
km/alpha−vmax)ˆ2+4/alpha ∗km∗min0 ) ˆ0 . 5 ) /(−2/ alpha ) }
38
#Set up func t i on s f o r c a l c u l a t i n g c y t o s o l i c minocyc l ine concent ra t i on .
40 #func t i on us ing v = tetx t imes kcat .
fmin <− f unc t i on (p , kcat , tetx , nadph , knadph , kmin , min0 ) {
42 vmax <− TetX Vmax(p , kcat , tetx , knadph , nadph )
km <− TetX kM(kmin , knadph , nadph )
44 km2 <− km/alpha
a <− −1/ alpha
46 b <− outer (km2+vmax , min0 , f unc t i on (x , y ) {y−x})
c <− outer (km, min0 )
48 MIN Free ( a , b , c )
}
50 #Sum of squares o f the d i f f e r e n c e between measured and pred i c t ed growth
r a t e s .
fsum <− f unc t i on (p) {
52 sum( ( t ( y1 [ ,− c ] ) − MinGrowth (p [ 1 : 2 ] , fmin (p [ 3 ] , kcat [−c ] , t e tx [−c ] , nadph ,
knadph[−c ] , kmin[−c ] , x1 ) ) ) ˆ2)
}
54 #Function us ing only v = kcat
#The two equat ions are used f o r to c a l c u l a t e e i t h e r the matrix or vec to r
o f growth ra t e va lue s .
56 fmin2 <− f unc t i on (d , kcat f , nadph f , knadph f , kmin f , min0 ) {
vmax <− TetX Vmax 2(d , kcat f , knadph f , nadph f )
58 km <− TetX kM(kmin f , knadph f , nadph f )
km2 <− km/alpha
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60 a <− −1/ alpha
b <− min0−km2−vmax
62 c <− km∗min0
MIN Free ( a , b , c )
64 }
fsum2 <− f unc t i on (p) {
66 kmin2 <− p [ 1 ]
kcat2 <− p [ 1 ] ∗p [ 2 ]
68 gr2 <− y1 [ , i ]
sum( ( t ( gr2 ) − MinGrowth(param [ 1 : 2 ] , fmin2 (param [ 3 ] , kcat2 , nadph , knadph
[ i ] , kmin2 , x1 ) ) ) ˆ2)
70 }
fmin3 <− f unc t i on (d , kcat f , nadph f , knadph f , kmin f , min0 ) {
72 vmax <− TetX Vmax 2(d , kcat f , knadph f , nadph f )
km <− TetX kM(kmin f , knadph f , nadph f )
74 km2 <− km/alpha
a <− −1/ alpha
76 b <− min0−km2−vmax
c <− km∗min0
78 MIN Free ( a , b , c )
}
80 fsum3 <− f unc t i on (p) {
kmin2 <− p
82 kcat2 <− kact m[ i ] ∗p
gr2 <− y1 [ , i ]
84 sum( ( t ( gr2 ) − MinGrowth(param [ 1 : 2 ] , fmin3 (param [ 3 ] , kcat2 , nadph , knadph
[ i ] , kmin2 , x1 ) ) ) ˆ2)
}
86 fmin4 <− f unc t i on (p , kcat , nadph , knadph , kmin , min0 ) {
vmax <− TetX Vmax 2(p , kcat , knadph , nadph )
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88 km <− TetX kM(kmin , knadph , nadph )
km2 <− km/alpha
90 a <− −1/ alpha
b <− outer (km2+vmax , min0 , f unc t i on (x , y ) {y−x})
92 c <− outer (km, min0 )
MIN Free ( a , b , c )
94 }
fsum4 <− f unc t i on (p) {
96 sum( ( t ( y1 ) − MinGrowth (p [ 1 : 2 ] , fmin4 (p [ 3 ] , kcat , nadph , knadph , kmin , x1 ) ) )
ˆ2)
}
98
#Model f i t t i n g us ing non−l i n e a r l e a s t squares o f the A, B, and D
parameters , removing mutant 9 , T280D .
100 param = NULL
c = 9
102 out = optim ( fsum , p = c (20 , 6 , 0 . 0 1 ) , h e s s i an = 1) ;
p r i n t ( out$ convergence )
104 param = out$par
p r i n t (param [ 1 : 2 ] )
106 pr in t (param [ 3 ] )
p <− param
108
#Model f i t t i n g f o r the k i n e t i c parameters o f a l l 9 mutants .
110 #I n i t i a l f i t f o r KM MCN and the r a t i o vmax/KM MCN using a s e t o f 2500
i n i t i a l c ond i t i on s .
kmin p <− NULL
112 kact p <− NULL
index <− NULL
114 minsum <− NULL
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n = 50
116 f o r ( k in 1 : n ) {
f o r ( j in 1 : n ) {
118 kmin pt <− NULL
kact pt <− NULL
120 minsum t <− NULL
f o r ( i in 1 : l ength ( kcat ) ) {
122 out2 = optim ( fsum2 , p = c ( ( k ) ∗2+10 ,( j ) ∗ 0 . 001 ) , h e s s i an = 1) ;
#pr in t ( c ( out2$ convergence , k , j ) )
124 kmin pt <− rbind ( kmin pt , out2$par [ 1 ] )
kact pt <− rbind ( kact pt , out2$par [ 2 ] )
126 minsum t <− rbind (minsum t , out2$ value )
}
128 index <− rbind ( index , c ( ( k ) ∗2+10 ,( j ) ∗ 0 . 001 ) )
kmin p <− cbind ( kmin p , kmin pt )
130 kact p <− cbind ( kact p , kact pt )
minsum <− cbind (minsum ,minsum t )
132 }
}
134
#Find the s o l u t i o n that bes t f i t s the maximum s l ope o f the o r i g i n a l
curve .
136 #Fi r s t dete rmin i e the s l ope o f the meeasured growth ra t e curve .
varB <− NULL
138 f o r ( i in 1 : ( l ength ( x1 )−4) ) {
varb <− ( colSums ( x1 [ i : ( i +4) ] ∗y1 [ i : ( i +4) , ] ) − 1/5∗ ( colSums ( y1 [ i : ( i +4)
, ] ) ∗sum( x1 [ i : ( i +4) ] ) ) ) / (sum( x1 [ i : ( i +4) ] ˆ 2 ) − 1/5∗ (sum( x1 [ i : ( i +4) ] )
) ˆ2)
140 varB <− rbind ( varB , varb )
}
143
142 varA <− NULL
varC <− NULL
144 #Determinne the s l o p e s o f the 2500 i nd i v i dua l s o l u t i o n s f o r each mutant .
f o r ( l in 1 : l ength ( kmin ) ) {
146 xp <− x1 [ which . min ( varB [ , l ] ) : ( which . min ( varB [ , l ] ) +4) ]
#xp <− x1 [ which . min ( ( y2 [ 1 : 8 , l ]−0.90) ˆ2) : ( which . min ( ( y2 [ 1 : 8 , l ]−0.90) ˆ2)
+3) ]
148 varC [ l ] <− min( varB [ , l ] )
#varC [ l ] <− varB [ which . min ( ( y2 [ 1 : 8 , l ]−0.90) ˆ2) , l ]
150 yp <− t (MinGrowth(p [ 1 : 2 ] , fmin4 (p [ 3 ] , kact p [ l , ] ∗kmin p [ l , ] , nadph ,
knadph [ l ] , kmin p [ l , ] , xp ) ) )
vara <− ( colSums (xp∗yp ) − 1/5∗ ( colSums (yp ) ∗sum(xp ) ) ) / (sum(xpˆ2) −
1/5∗ (sum(xp ) ˆ2) )
152 varA <− cbind (varA , vara )
}
154 #Find the s o l u t i o n that bes t f i t s the s l ope to determine the pr ed i c t ed
vmax/KM MCN.
colnames ( varA ) <− colnames ( y1 )
156 kmin ps <− NULL
kact ps <− NULL
158 f i t b e t a <− NULL
f o r ( i in 1 : l ength ( kcat ) ) {
160 f i t b e t a [ i ] <− which . min ( ( varA [ , i ] − varC [ i ] ) ˆ2)
kmin ps <− rbind ( kmin ps , kmin p [ i , f i t b e t a [ i ] ] )
162 kact ps <− rbind ( kact ps , kact p [ i , f i t b e t a [ i ] ] )
}
164
#Print the o r i g i n a l parameter f i t s o l u t i o n curves and the s e t o f
s o l u t i o n curves from the f i r s t two s t ep s f o r the k i n e t i c parameters
f i t .
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166 t i f f ( f i l e = paste ( Sys . Date ( ) , run , ’ s o l u t i o n s ’ , sep = ’ ’ ) ,
width = 16 .0 , he ight = 8 . 7 , un i t s = ’cm ’ ,
168 r e s = 800 , a n t i a l i a s = ’ d e f au l t ’ )
170 mutnames = names ( g r a t e s )
par (mfrow = c (2 , 5 ) , oma = c (4 , 4 , 1 , 1 ) ,mar = c (0 , 0 , 1 , 0 ) , xpd = NA)
172 l b l = c ( ’ y ’ , ’ n ’ , ’ n ’ , ’ n ’ , ’ n ’ , ’ b ’ , ’ x ’ , ’ x ’ , ’ x ’ )
f o r ( l in 1 : l ength ( kcat ) ) {
174 p lo t ( g r a t e s [ , 1 ] , g r a t e s [ , l +1] , xl im = ( c (0 , g r a t e s [ l ength ( x1 ) , 1 ] ) ) , yl im
= c (0 , 1 ) ,
l a b e l s = F, frame . p l o t = T, xlab = NA, ylab = NA, xaxp = c
(0 , 80 , 4 ) , pch = 20 , cex = 0 . 66 ) ;
176 f o r ( i in 1 : l ength ( kmin p [ l , ] ) ) {
curve (MinGrowth as in2 (p [ 1 : 2 ] , fmin3 (p [ 3 ] , kact p [ l , i ] ∗kmin p [ l , i ] ,
nadph , knadph [ l ] , kmin p [ l , i ] , x ) ) ,
178 0 , max( x1 ) , add = T, lwd = 0 . 1 )
}
180
curve (MinGrowth as in2 (p [ 1 : 2 ] , fmin3 (p [ 3 ] , kact ps [ l ] ∗kmin ps [ l ] , nadph ,
knadph [ l ] , kmin ps [ l ] , x ) ) ,
182 0 , max( x1 ) , add = T, lwd = 0 . 3 , c o l = 2)
mtext ( paste (mutnames [ l +1] , ’ ’ ) , outer = F, s i d e = 3 , adj = 1 , l i n e
= −1.5 , cex = 0 . 6 )
184 i f ( l b l [ l ] == ’x ’ ) {
ax i s ( s i d e = 1 , t i c k = F, c in = 6/72)
186 } e l s e i f ( l b l [ l ] == ’y ’ ) {
ax i s ( s i d e = 2 , t i c k = F, at = c ( 0 , 0 . 5 , 1 ) , c in = 6/72)
188 } e l s e i f ( l b l [ l ] == ’b ’ ) {
ax i s ( s i d e = 1 , t i c k = F)
190 ax i s ( s i d e = 2 , t i c k = F, at = c ( 0 , 0 . 5 , 1 ) , c in = 6/72)
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}
192 }
mtext ( paste ( ’A) ’ ) , l i n e = 1 . 2 , outer = T, c in = 6/ 72 , adj = 0)
194 mtext ( exp r e s s i on ( paste ( ’ Minocyc l ine ’ , ’ ( ’ , mu, ’ g/ml ) ’ ) ) , outer = T, s i d e
= 1 , l i n e = 2 . 2 , c in = 6/72)
mtext ( ’Growth Rate ’ , outer = T, s i d e = 2 , l i n e = 2 . 4 )
196 dev . o f f ( )
198 t i f f ( f i l e = paste ( Sys . Date ( ) , run , ’ r a t i o s ’ , sep = ’ ’ ) ,
width = 16 .0 , he ight = 8 . 7 , un i t s = ’cm ’ ,
200 r e s = 800 , a n t i a l i a s = ’ d e f au l t ’ )
mutnames = names ( g r a t e s )
202 par (mfrow = c (2 , 5 ) , oma = c (4 , 4 , 1 , 1 ) ,mar = c (0 , 0 , 1 , 0 ) , xpd = NA)
l b l = c ( ’ y ’ , ’ n ’ , ’ n ’ , ’ n ’ , ’ n ’ , ’ b ’ , ’ x ’ , ’ x ’ , ’ x ’ )
204 f o r ( l in 1 : l ength ( kcat ) ) {
p lo t ( g r a t e s [ , 1 ] , g r a t e s [ , l +1] , xl im = ( c (0 , g r a t e s [ l ength ( x1 ) , 1 ] ) ) , yl im
= c (0 , 1 ) ,
206 l a b e l s = F, frame . p l o t = T, xlab = NA, ylab = NA, xaxp = c (0 , 80 , 4 ) ,
pch = 20 , cex = 0 .66 , c o l = 3)
f o r ( i in 1 :1000) {
208 curve (MinGrowth as in2 (p [ 1 : 2 ] , fmin3 (p [ 3 ] , kact ps [ l ] ∗kmin ps [ l ] ∗ ( i /
100) , nadph , knadph [ l ] , kmin ps [ l ] ∗ ( i / 100) , x ) ) ,
0 , max( x1 ) , add = T, lwd = 0 . 1 )
210 }
curve (MinGrowth as in2 (p [ 1 : 2 ] , fmin3 (p [ 3 ] , kact ps [ l ] ∗kmin ps [ l ] , nadph ,
knadph [ l ] , kmin ps [ l ] , x ) ) ,
212 0 , max( x1 ) , add = T, lwd = 0 . 3 , c o l = 2)
mtext ( paste (mutnames [ l +1] , ’ ’ ) , outer = F, s i d e = 3 , adj = 1 . 2 , l i n e
= −1.2 , cex = 0 . 6 )
214 i f ( l b l [ l ] == ’x ’ ) {
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ax i s ( s i d e = 1 , t i c k = F, c in = 6/72)
216 } e l s e i f ( l b l [ l ] == ’y ’ ) {
ax i s ( s i d e = 2 , t i c k = F, at = c ( 0 , 0 . 5 , 1 ) , c in = 6/72)
218 } e l s e i f ( l b l [ l ] == ’b ’ ) {
ax i s ( s i d e = 1 , t i c k = F)
220 ax i s ( s i d e = 2 , t i c k = F, at = c ( 0 , 0 . 5 , 1 ) , c in = 6/72)
}
222 }
mtext ( paste ( ’A) ’ ) , l i n e = 1 . 2 , outer = T, c in = 6/ 72 , adj = 0)
224 mtext ( exp r e s s i on ( paste ( ’ Minocyc l ine ’ , ’ ( ’ , mu, ’ g/ml ) ’ ) ) , outer = T, s i d e
= 1 , l i n e = 2 . 2 , c in = 6/72)
mtext ( ’Growth Rate ’ , outer = T, s i d e = 2 , l i n e = 2 . 4 )
226 dev . o f f ( )
228 #Fit f o r KM MCN us ing a second l e a s t squares f i t with the r a t i o o f vmax/
KM MCN determined from the prev ious f i t .
kact m <− kact ps
230 #kact m <− apply ( kact p , 1 ,mean)
232 kmin pd <− NULL
kcat pd <− NULL
234 f o r ( i in 1 : 9 ) {
out3 = optim ( fsum3 , p = 50 , he s s i an = 1) ;
236 pr in t ( c ( out3$ convergence ) )
kmin pd <− rbind ( kmin pd , out3$par [ 1 ] )
238 kcat pd <− rbind ( kcat pd , out3$par [ 1 ] ∗kact m[ i ] )
}
240
#Print curves o f the p r ed i c t ed growth r a t e s us ing the pr ed i c t ed k i n e t i c
parameters f o r each mutant .
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242 t i f f ( f i l e = paste ( Sys . Date ( ) , run , ’ s o lu t i on− f i n a l ’ , sep = ’ ’ ) ,
width = 16 .0 , he ight = 8 . 7 , un i t s = ’cm ’ ,
244 r e s = 800 , a n t i a l i a s = ’ d e f au l t ’ )
246 mutnames = names ( g r a t e s )
par (mfrow = c (2 , 5 ) , oma = c (4 , 4 , 1 , 1 ) ,mar = c (0 , 0 , 1 , 0 ) , xpd = NA)
248 l b l = c ( ’ y ’ , ’ n ’ , ’ n ’ , ’ n ’ , ’ n ’ , ’ b ’ , ’ x ’ , ’ x ’ , ’ x ’ )
f o r ( l in 1 : l ength ( kcat ) ) {
250 p lo t ( g r a t e s [ , 1 ] , g r a t e s [ , l +1] , xl im = ( c (0 , g r a t e s [ l ength ( x1 ) , 1 ] ) ) , yl im
= c (0 , 1 ) ,
l a b e l s = F, frame . p l o t = T, xlab = NA, ylab = NA, xaxp = c (0 , 80 , 4 ) ,
pch = 20 , cex = 0 . 66 ) ;
252 curve (MinGrowth as in2 (p [ 1 : 2 ] , fmin3 (p [ 3 ] , kcat pd [ l ] , nadph , knadph [ l ] ,
kmin pd [ l ] , x ) ) ,
0 , max( x1 ) , add = T, lwd = 0 . 3 , c o l = 2)
254 mtext ( paste (mutnames [ l +1] , ’ ’ ) , outer = F, s i d e = 3 , adj = 1 , l i n e =
−1.5 , cex = 0 . 6 )
i f ( l b l [ l ] == ’x ’ ) {
256 ax i s ( s i d e = 1 , t i c k = F, c in = 6/72)
} e l s e i f ( l b l [ l ] == ’y ’ ) {
258 ax i s ( s i d e = 2 , t i c k = F, at = c ( 0 , 0 . 5 , 1 ) , c in = 6/72)
} e l s e i f ( l b l [ l ] == ’b ’ ) {
260 ax i s ( s i d e = 1 , t i c k = F)
ax i s ( s i d e = 2 , t i c k = F, at = c ( 0 , 0 . 5 , 1 ) , c in = 6/72)
262 }
}
264 mtext ( paste ( ’A) ’ ) , l i n e = 1 . 2 , outer = T, c in = 6/ 72 , adj = 0)
mtext ( exp r e s s i on ( paste ( ’ Minocyc l ine ’ , ’ ( ’ , mu, ’ g/ml ) ’ ) ) , outer = T, s i d e
= 1 , l i n e = 2 . 2 , c in = 6/72)
266 mtext ( ’Growth Rate ’ , outer = T, s i d e = 2 , l i n e = 2 . 4 )
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dev . o f f ( )
268
#Write and pr in t r e s u l t s
270 Resu l t s <− data . frame ( ’KM MCN’ = kmin pd , ’Vmax ’ = kcat pd , ’ Ac t i v i t y ’ =
kact m)
rownames ( Resu l t s ) <− mutnames [ 2 : 1 0 ]
272
pr in t ( Resu l t s )
274
wr i t e . t ab l e ( Results , f i l e = paste ( Sys . Date ( ) , run , ’ Resu l t s ’ , sep = ’ ’ ) ,
sep = ’ , ’ , row . names = T, c o l . names = T)
276
t i f f ( f i l e = paste ( Sys . Date ( ) , run , ’ Figure5−s o l u t i o n s ’ , sep = ’ ’ ) ,
278 width = 5 . 5 , he ight = 5 . 5 , un i t s = ’cm ’ ,
r e s = 1200 , a n t i a l i a s = ’ d e f au l t ’ )
280
mutnames = names ( g r a t e s )
282 par (mfrow = c (2 , 5 ) , oma = c (4 , 4 , 1 , 1 ) ,mar = c (0 , 0 , 1 , 0 ) , xpd = NA)
l b l = c ( ’ y ’ , ’ n ’ , ’ n ’ , ’ n ’ , ’ n ’ , ’ b ’ , ’ x ’ , ’ x ’ , ’ x ’ )
284 f o r ( l in 1 : l ength ( kcat ) ) {
p lo t ( g r a t e s [ , 1 ] , g r a t e s [ , l +1] , xl im = ( c (0 , g r a t e s [ l ength ( x1 ) , 1 ] ) ) , yl im
= c (0 , 1 ) ,
286 l a b e l s = F, frame . p l o t = T, xlab = NA, ylab = NA, xaxp = c
(0 , 80 , 4 ) , pch = 1 , cex = 0 . 66 ) ;
curve (MinGrowth as in2 (p [ 1 : 2 ] , fmin (p [ 3 ] , kcat [ l ] , t e tx [ l ] , nadph ,
knadph [ l ] , kmin [ l ] , x ) ) ,
288 0 , max( x1 ) , add = T, lwd = 1)
curve (MinGrowth as in2 (p [ 1 : 2 ] , fmin3 (p [ 3 ] , kact ps [ l ] ∗kmin ps [ l ] , nadph ,
knadph [ l ] , kmin ps [ l ] , x ) ) ,
290 0 , max( x1 ) , add = T, lwd = 1 , l t y = ’ dashed ’ , c o l = 2)
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mtext ( paste (mutnames [ l +1] , ’ ’ ) , outer = F, s i d e = 3 , adj = 1 . 2 ,
l i n e = −0.8 , cex = 0 . 4 )
292 i f ( l b l [ l ] == ’x ’ ) {
ax i s ( s i d e = 1 , t i c k = F, c in = 6/72)
294 } e l s e i f ( l b l [ l ] == ’y ’ ) {
ax i s ( s i d e = 2 , t i c k = F, at = c ( 0 , 0 . 5 , 1 ) , c in = 6/72)
296 } e l s e i f ( l b l [ l ] == ’b ’ ) {
ax i s ( s i d e = 1 , t i c k = F)
298 ax i s ( s i d e = 2 , t i c k = F, at = c ( 0 , 0 . 5 , 1 ) , c in = 6/72)
}
300 }
mtext ( paste ( ’A) ’ ) , l i n e = 1 . 2 , outer = T, c in = 6/ 72 , adj = 0)
302 mtext ( exp r e s s i on ( paste ( ’ Minocyc l ine ’ , ’ ( ’ , mu, ’ g/ml ) ’ ) ) , outer = T, s i d e
= 1 , l i n e = 2 . 2 , c in = 6/72)
mtext ( ’Growth Rate ’ , outer = T, s i d e = 2 , l i n e = 2 . 4 )
304 dev . o f f ( )
Listing B.2: R script for Growth Rate Function of TetX2
B.3 R Script for Jackknife Method
rm( l i s t=l s ( ) )
2 #Read data f o r growth r a t e s and k i n e t i c s .
g r a t e s = read . t ab l e ( ’ GrowthRates Norm3−2. txt ’ , header = TRUE)
4 k i n e t i c s = read . t ab l e ( ’TetX2 k i n e t i c s 3 −2. txt ’ , header = TRUE)
runs = c ( ’B1 ’ , ’B2 ’ , ’B3 ’ , ’B4 ’ , ’B5 ’ , ’B6 ’ , ’B7 ’ , ’B8 ’ )
6
#Set up va r i a b l e s and cons tant s .
8 bgr = gra t e s [ , 1 0 ]
min = gra t e s [ , 1 ]
150
10 #Kine t i c s cons tant s .
kcat = k i n e t i c s [ , 3 ]
12 t e tx = k i n e t i c s [ , 5 ] / k i n e t i c s [ , 3 ]
knadph = k i n e t i c s [ , 2 ]
14 kmin = k i n e t i c s [ , 1 ]
grmax = 1 .0
16 #Growth ra t e data .
x1 = gra t e s [ , 1 ]
18 y2 = gra t e s [ , 2 : 9 ]
y1 = as in ( ( g r a t e s [ , 2 : 9 ] ) ˆ0 . 5 )
20 y1 [ i s . nan ( y1 ) ] = as in (1 )
nadph = 150
22 alpha = 4
24 #Fit the no−TetX growth curve us ing a h i l l equat ion ; f unc t i on i s the
growth ra t e dependent on minocyc l ine i n s i d e the c e l l .
MinGrowth = func t i on ( pargr , min ) { as in ((1−minˆpargr [ 2 ] / ( pargr [1 ]+minˆ pargr
[ 2 ] ) ) ˆ0 . 5 ) }
26 MinGrowth as in2 = func t i on ( pargr , min ){1−minˆpargr [ 2 ] / ( pargr [1 ]+minˆ pargr
[ 2 ] ) }
28 #Set up equat ions f o r c a l c u l a t i n g minocyc l ine concent ra t i on i n s i d e the
c e l l .
TetX Vmax = func t i on (D, kcat , tetx , knadph , nadph ) {( kcat ∗ t e tx /D) ∗nadph/ (
knadph+nadph ) }
30 TetX Vmax 2 = func t i on (D, kcat , knadph , nadph ) {( kcat /D) ∗nadph/ ( knadph+nadph
) }
TetX kM = func t i on (kmin , knadph , nadph ) {kmin∗nadph/ ( knadph+nadph ) }
32 MIN Free = func t i on (a , b , c ){(−b−(bˆ2−4∗a∗c ) ˆ0 . 5 ) / (2 ∗a ) }
151
MIN Free2 = func t i on (vmax ,km, min0 , alpha ) {(−(min0−km/alpha−vmax)−((min0−
km/alpha−vmax)ˆ2+4/alpha ∗km∗min0 ) ˆ0 . 5 ) /(−2/ alpha ) }
34
#Fit a l l data with dr , nadph , and te tx as v a r i a b l e s . t e tx can vary
between mutants .
36 fmin <− f unc t i on (p , kcat , tetx , nadph , knadph , kmin , min0 ) {
vmax <− TetX Vmax(p , kcat , tetx , knadph , nadph )
38 km <− TetX kM(kmin , knadph , nadph )
km2 <− km/alpha
40 a <− −1/ alpha
b <− outer (km2+vmax , min0 , f unc t i on (x , y ) {y−x})
42 c <− outer (km, min0 )
MIN Free ( a , b , c )
44 }
fsum <− f unc t i on (p) {
46 sum( ( t ( y1 [ ,− c ] ) − MinGrowth (p [ 1 : 2 ] , fmin (p [ 3 ] , kcat [−c ] , t e tx [−c ] , nadph ,
knadph[−c ] , kmin[−c ] , x1 ) ) ) ˆ2)
}
48 fmin2 <− f unc t i on (d , kcat f , nadph f , knadph f , kmin f , min0 ) {
vmax <− TetX Vmax 2(d , kcat f , knadph f , nadph f )
50 km <− TetX kM(kmin f , knadph f , nadph f )
km2 <− km/alpha
52 a <− −1/ alpha
b <− min0−km2−vmax
54 c <− km∗min0
MIN Free ( a , b , c )
56 }
fsum2 <− f unc t i on (p) {
58 kmin2 <− p [ 1 ]
kcat2 <− p [ 1 ] ∗p [ 2 ]
152
60 gr2 <− y1 [ , i ]
sum( ( t ( gr2 ) − MinGrowth(param [ 1 : 2 ] , fmin2 (param [ 3 ] , kcat2 , nadph , knadph
[ i ] , kmin2 , x1 ) ) ) ˆ2)
62 }
fmin3 <− f unc t i on (d , kcat f , nadph f , knadph f , kmin f , min0 ) {
64 vmax <− TetX Vmax 2(d , kcat f , knadph f , nadph f )
km <− TetX kM(kmin f , knadph f , nadph f )
66 km2 <− km/alpha
a <− −1/ alpha
68 b <− min0−km2−vmax
c <− km∗min0
70 MIN Free ( a , b , c )
}
72 fsum3 <− f unc t i on (p) {
kmin2 <− p
74 kcat2 <− kact m[ i ] ∗p
gr2 <− y1 [ , i ]
76 sum( ( t ( gr2 ) − MinGrowth(param [ 1 : 2 ] , fmin3 (param [ 3 ] , kcat2 , nadph , knadph
[ i ] , kmin2 , x1 ) ) ) ˆ2)
}
78 fmin4 <− f unc t i on (p , kcat , nadph , knadph , kmin , min0 ) {
vmax <− TetX Vmax 2(p , kcat , knadph , nadph )
80 km <− TetX kM(kmin , knadph , nadph )
km2 <− km/alpha
82 a <− −1/ alpha
b <− outer (km2+vmax , min0 , f unc t i on (x , y ) {y−x})
84 c <− outer (km, min0 )
MIN Free ( a , b , c )
86 }
fsum4 <− f unc t i on (p) {
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88 sum( ( t ( y1 ) − MinGrowth (p [ 1 : 2 ] , fmin4 (p [ 3 ] , kcat , nadph , knadph , kmin , x1 ) ) )
ˆ2)
}
90
parameters <− NULL
92 f o r ( c in c ( 1 : 8 ) ) {
#Model f i t t i n g us ing non−l i n e a r l e a s t squares .
94 param = NULL
out = optim ( fsum , p = c ( 2 0 , 2 . 3 , 0 . 0 0 1 ) , h e s s i an = 1) ;
96 pr in t ( out$ convergence )
param = out$par
98 pr in t (param [ 1 : 2 ] )
p r i n t (param [ 3 ] )
100 p <− param
parameters <− rbind ( parameters , p )
102 run <− runs [ c ]
a s s i gn ( paste ( ’ out ’ , run , sep = ’ ’ ) , out )
104
106 kmin p <− NULL
kact p <− NULL
108 index <− NULL
minsum <− NULL
110 n = 50
f o r ( k in 1 : n ) {
112 f o r ( j in 1 : n ) {
kmin pt <− NULL
114 kact pt <− NULL
minsum t <− NULL
116 f o r ( i in 1 : l ength ( kcat ) ) {
154
out2 = optim ( fsum2 , p = c ( ( k ) ∗2+10 ,( j ) ∗ 0.001+0.001) , h e s s i an
= 1) ;
118 pr in t ( c ( out2$ convergence , k , j ) )
kmin pt <− rbind ( kmin pt , out2$par [ 1 ] )
120 kact pt <− rbind ( kact pt , out2$par [ 2 ] )
minsum t <− rbind (minsum t , out2$ value )
122 }
index <− rbind ( index , c ( ( k ) ∗2+10 ,( j ) ∗ 0 . 001 ) )
124 kmin p <− cbind ( kmin p , kmin pt )
kact p <− cbind ( kact p , kact pt )
126 minsum <− cbind (minsum ,minsum t )
}
128 }
130 varB <− NULL
f o r ( i in 1 : ( l ength ( x1 )−4) ) {
132 varb <− ( colSums ( x1 [ i : ( i +4) ] ∗y1 [ i : ( i +4) , ] ) − 1/5∗ ( colSums ( y1 [ i : ( i +4)
, ] ) ∗sum( x1 [ i : ( i +4) ] ) ) ) / (sum( x1 [ i : ( i +4) ] ˆ 2 ) − 1/5∗ (sum( x1 [ i : ( i +4)
] ) ) ˆ2)
varB <− rbind ( varB , varb )
134 }
varA <− NULL
136 varC <− NULL
y3 <− NULL
138 f o r ( i in 2 : 8 ) {
yt <− colMeans ( y2 [ i −1: i +1 , ] )
140 y3 <− rbind ( y3 , yt )
}
142 f o r ( l in 1 : l ength ( kmin ) ) {
xp <− x1 [ which . min ( varB [ , l ] ) : ( which . min ( varB [ , l ] ) +4) ]
155
144 #xp <− x1 [ ( which . min ( ( y2 [ 3 : 6 , l ]−0.5) ˆ2) ) : ( which . min ( ( y2 [ 3 : 6 , l ]−0.5)
ˆ2)+4) ]
varC [ l ] <− min( varB [ , l ] )
146 #varC [ l ] <− varB [ which . min ( ( y2 [ 3 : 6 , l ]−0.5) ˆ2)+2, l ]
yp <− t (MinGrowth(p [ 1 : 2 ] , fmin4 (p [ 3 ] , kact p [ l , ] ∗kmin p [ l , ] , nadph ,
knadph [ l ] , kmin p [ l , ] , xp ) ) )
148 vara <− ( colSums (xp∗yp ) − 1/5∗ ( colSums (yp ) ∗sum(xp ) ) ) / (sum(xpˆ2)
− 1/5∗ (sum(xp ) ˆ2) )
varA <− cbind (varA , vara )
150 }
colnames ( varA ) <− colnames ( y1 )
152 kmin ps <− NULL
kact ps <− NULL
154 f i t b e t a <− NULL
f o r ( i in 1 : l ength ( kcat ) ) {
156 f i t b e t a [ i ] <− which . min ( ( varA [ , i ] − varC [ i ] ) ˆ2)
kmin ps <− rbind ( kmin ps , kmin p [ i , f i t b e t a [ i ] ] )
158 kact ps <− rbind ( kact ps , kact p [ i , f i t b e t a [ i ] ] )
}
160
t i f f ( f i l e = paste ( Sys . Date ( ) , run , ’ s o l u t i o n s ’ , sep = ’ ’ ) ,
162 width = 16 . 0 , he ight = 8 . 7 , un i t s = ’cm ’ ,
r e s = 800 , a n t i a l i a s = ’ d e f au l t ’ )
164
mutnames = names ( g r a t e s )
166 par (mfrow = c (2 , 4 ) , oma = c (4 , 4 , 1 , 1 ) ,mar = c (0 , 0 , 1 , 0 ) , xpd = NA)
l b l = c ( ’ y ’ , ’ n ’ , ’ n ’ , ’ n ’ , ’ b ’ , ’ x ’ , ’ x ’ , ’ x ’ )
168 f o r ( l in 1 : l ength ( kcat ) ) {
p lo t ( g r a t e s [ , 1 ] , g r a t e s [ , l +1] , xl im = ( c (0 , g r a t e s [ l ength ( x1 ) , 1 ] ) ) ,
yl im = c (0 , 1 ) ,
156
170 l a b e l s = F, frame . p l o t = T, xlab = NA, ylab = NA, xaxp = c
(0 , 80 , 4 ) , pch = 20 , cex = 0 . 66 ) ;
f o r ( i in 1 : l ength ( kmin p [ l , ] ) ) {
172 curve (MinGrowth as in2 (p [ 1 : 2 ] , fmin3 (p [ 3 ] , kact p [ l , i ] ∗kmin p [ l , i ] ,
nadph , knadph [ l ] , kmin p [ l , i ] , x ) ) ,
0 , max( x1 ) , add = T, lwd = 0 . 1 )
174 }
176 curve (MinGrowth as in2 (p [ 1 : 2 ] , fmin3 (p [ 3 ] , kact ps [ l ] ∗kmin ps [ l ] ,
nadph , knadph [ l ] , kmin ps [ l ] , x ) ) ,
0 , max( x1 ) , add = T, lwd = 0 . 3 , c o l = 2)
178 mtext ( paste (mutnames [ l +1] , ’ ’ ) , outer = F, s i d e = 3 , adj = 1 ,
l i n e = −1.5 , cex = 0 . 6 )
i f ( l b l [ l ] == ’x ’ ) {
180 ax i s ( s i d e = 1 , t i c k = F, c in = 6/72)
} e l s e i f ( l b l [ l ] == ’y ’ ) {
182 ax i s ( s i d e = 2 , t i c k = F, at = c ( 0 , 0 . 5 , 1 ) , c in = 6/72)
} e l s e i f ( l b l [ l ] == ’b ’ ) {
184 ax i s ( s i d e = 1 , t i c k = F)
ax i s ( s i d e = 2 , t i c k = F, at = c ( 0 , 0 . 5 , 1 ) , c in = 6/72)
186 }
}
188 mtext ( paste ( ’A) ’ ) , l i n e = 1 . 2 , outer = T, c in = 6/ 72 , adj = 0)
mtext ( ’ Minocyc l ine ( ug/ml ) ’ , outer = T, s i d e = 1 , l i n e = 2 . 2 , c in = 6/
72)
190 mtext ( ’Growth Rate ’ , outer = T, s i d e = 2 , l i n e = 2 . 4 )
dev . o f f ( )
192
t i f f ( f i l e = paste ( Sys . Date ( ) , run , ’ r a t i o s ’ , sep = ’ ’ ) ,
194 width = 16 . 0 , he ight = 8 . 7 , un i t s = ’cm ’ ,
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r e s = 800 , a n t i a l i a s = ’ d e f au l t ’ )
196 mutnames = names ( g r a t e s )
par (mfrow = c (2 , 4 ) , oma = c (4 , 4 , 1 , 1 ) ,mar = c (0 , 0 , 1 , 0 ) , xpd = NA)
198 l b l = c ( ’ y ’ , ’ n ’ , ’ n ’ , ’ n ’ , ’ b ’ , ’ x ’ , ’ x ’ , ’ x ’ )
f o r ( l in 1 : l ength ( kcat ) ) {
200 p lo t ( g r a t e s [ , 1 ] , g r a t e s [ , l +1] , xl im = ( c (0 , g r a t e s [ l ength ( x1 ) , 1 ] ) ) ,
yl im = c (0 , 1 ) ,
l a b e l s = F, frame . p l o t = T, xlab = NA, ylab = NA, xaxp = c (0 , 80 , 4 )
, pch = 20 , cex = 0 .66 , c o l = 3)
202 f o r ( i in 1 :1000) {
curve (MinGrowth as in2 (p [ 1 : 2 ] , fmin3 (p [ 3 ] , kact ps [ l ] ∗kmin ps [ l ] ∗ ( i /
100) , nadph , knadph [ l ] , kmin ps [ l ] ∗ ( i / 100) , x ) ) ,
204 0 , max( x1 ) , add = T, lwd = 0 . 1 )
}
206 curve (MinGrowth as in2 (p [ 1 : 2 ] , fmin3 (p [ 3 ] , kact ps [ l ] ∗kmin ps [ l ] , nadph ,
knadph [ l ] , kmin ps [ l ] , x ) ) ,
0 , max( x1 ) , add = T, lwd = 0 . 3 , c o l = 2)
208 mtext ( paste (mutnames [ l +1] , ’ ’ ) , outer = F, s i d e = 3 , adj = 1 , l i n e
= −1.5 , cex = 0 . 6 )
i f ( l b l [ l ] == ’x ’ ) {
210 ax i s ( s i d e = 1 , t i c k = F, c in = 6/72)
} e l s e i f ( l b l [ l ] == ’y ’ ) {
212 ax i s ( s i d e = 2 , t i c k = F, at = c ( 0 , 0 . 5 , 1 ) , c in = 6/72)
} e l s e i f ( l b l [ l ] == ’b ’ ) {
214 ax i s ( s i d e = 1 , t i c k = F)
ax i s ( s i d e = 2 , t i c k = F, at = c ( 0 , 0 . 5 , 1 ) , c in = 6/72)
216 }
}
218 mtext ( paste ( ’A) ’ ) , l i n e = 1 . 2 , outer = T, c in = 6/ 72 , adj = 0)
158
mtext ( ’ Minocyc l ine ( ug/ml ) ’ , outer = T, s i d e = 1 , l i n e = 2 . 2 , c in = 6/
72)
220 mtext ( ’Growth Rate ’ , outer = T, s i d e = 2 , l i n e = 2 . 4 )
dev . o f f ( )
222
kact m <− kact ps
224 #kact m <− apply ( kact p , 1 ,mean)
226 kmin pd <− NULL
kcat pd <− NULL
228 f o r ( i in 1 : 8 ) {
out3 = optim ( fsum3 , p = 50 , he s s i an = 1) ;
230 pr in t ( c ( out3$ convergence ) )
kmin pd <− rbind ( kmin pd , out3$par [ 1 ] )
232 kcat pd <− rbind ( kcat pd , out3$par [ 1 ] ∗kact m[ i ] )
}
234
t i f f ( f i l e = paste ( Sys . Date ( ) , run , ’ s o lu t i on− f i n a l ’ , sep = ’ ’ ) ,
236 width = 16 . 0 , he ight = 8 . 7 , un i t s = ’cm ’ ,
r e s = 800 , a n t i a l i a s = ’ d e f au l t ’ )
238
mutnames = names ( g r a t e s )
240 par (mfrow = c (2 , 4 ) , oma = c (4 , 4 , 1 , 1 ) ,mar = c (0 , 0 , 1 , 0 ) , xpd = NA)
l b l = c ( ’ y ’ , ’ n ’ , ’ n ’ , ’ n ’ , ’ b ’ , ’ x ’ , ’ x ’ , ’ x ’ )
242 f o r ( l in 1 : l ength ( kcat ) ) {
p lo t ( g r a t e s [ , 1 ] , g r a t e s [ , l +1] , xl im = ( c (0 , g r a t e s [ l ength ( x1 ) , 1 ] ) ) ,
yl im = c (0 , 1 ) ,
244 l a b e l s = F, frame . p l o t = T, xlab = NA, ylab = NA, xaxp = c (0 , 80 , 4 )
, pch = 20 , cex = 0 . 66 ) ;
159
curve (MinGrowth as in2 (p [ 1 : 2 ] , fmin3 (p [ 3 ] , kcat pd [ l ] , nadph , knadph [ l ] ,
kmin pd [ l ] , x ) ) ,
246 0 , max( x1 ) , add = T, lwd = 0 . 3 , c o l = 2)
mtext ( paste (mutnames [ l +1] , ’ ’ ) , outer = F, s i d e = 3 , adj = 1 , l i n e
= −1.5 , cex = 0 . 6 )
248 i f ( l b l [ l ] == ’x ’ ) {
ax i s ( s i d e = 1 , t i c k = F, c in = 6/72)
250 } e l s e i f ( l b l [ l ] == ’y ’ ) {
ax i s ( s i d e = 2 , t i c k = F, at = c ( 0 , 0 . 5 , 1 ) , c in = 6/72)
252 } e l s e i f ( l b l [ l ] == ’b ’ ) {
ax i s ( s i d e = 1 , t i c k = F)
254 ax i s ( s i d e = 2 , t i c k = F, at = c ( 0 , 0 . 5 , 1 ) , c in = 6/72)
}
256 }
mtext ( paste ( ’A) ’ ) , l i n e = 1 . 2 , outer = T, c in = 6/ 72 , adj = 0)
258 mtext ( ’ Minocyc l ine ( ug/ml ) ’ , outer = T, s i d e = 1 , l i n e = 2 . 2 , c in = 6/
72)
mtext ( ’Growth Rate ’ , outer = T, s i d e = 2 , l i n e = 2 . 4 )
260 dev . o f f ( )
262 Resu l t s <− data . frame ( ’KM MCN’ = kmin pd , ’Vmax ’ = kcat pd , ’ Ac t i v i t y ’
= kact m)
rownames ( Resu l t s ) <− mutnames [ 2 : 9 ]
264 a s s i gn ( paste ( ’ Resu l t s ’ , run , sep = ’ ’ ) , Resu l t s )
266 wr i t e . t ab l e ( Results , f i l e = paste ( Sys . Date ( ) , run , ’ Resu l t s ’ , sep = ’ ’ ) ,
sep = ’ , ’ , row . names = T, c o l . names = T)
}
268
pr in t ( Resu l t s B1)
160
270 pr in t ( Resu l t s B2)
p r i n t ( Resu l t s B3)
272 pr in t ( Resu l t s B4)
p r i n t ( Resu l t s B5)
274 pr in t ( Resu l t s B6)
p r i n t ( Resu l t s B7)
276 pr in t ( Resu l t s B8)
p r i n t ( parameters )
278
wr i t e . t ab l e ( parameters , f i l e = paste ( Sys . Date ( ) , ’B ’ , ’ Parameters ’ , sep = ’
’ ) , sep = ’ , ’ , row . names = F, c o l . names = F)
Listing B.3: R script for Growth Rate Function of TetX2
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Appendix C
Jackknife Results
Table C.1: Estimate of kinetic parameters using jackknife method model parameters
TetX2 removed KM(MCN) Vmax Vmax/KM(MCN)
(µM) (s-1) (µM -1 s-1)
TetX2 28.62 0.1 0.0035
T280A 5.93 0.12 0.02
F235Y 101.45 0.56 0.0055
K64R 13.02 0.06 0.0046
N371I 29.61 0.4 0.0136
N371T 19.11 0.25 0.0133
S326I 96.56 0.6 0.0062
162
T280S 18.79 0.07 0.0039
T280A removed KM(MCN) Vmax Vmax/KM(MCN)
(µM) (s-1) (µM -1 s-1)
TetX2 23.68 0.09 0.004
T280A 5.09 0.12 0.0229
F235Y 74.02 0.47 0.0063
K64R 20.37 0.08 0.004
N371I 32.11 0.46 0.0144
N371T 22.14 0.29 0.0132
S326I 83.2 0.58 0.0069
T280S 18.96 0.08 0.0041
F235Y removed KM(MCN) Vmax Vmax/KM(MCN)
(µM) (s-1) (µM -1 s-1)
TetX2 26.74 0.11 0.0041
T280A 1.24 0.02 0.0194
F235Y 1966125 14659.72 0.0075
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K64R 62.03 0.22 0.0036
N371I 3932205 56785.22 0.0144
N371T 5242925 56382.73 0.0108
S326I 3932205 31277.96 0.008
T280S 18.34 0.07 0.0039
K64R removed KM(MCN) Vmax Vmax/KM(MCN)
(µM) (s-1) (µM -1 s-1)
TetX2 15.8 0.07 0.0045
T280A 5.75 0.11 0.0199
F235Y 87.91 0.51 0.0058
K64R 13.13 0.06 0.0046
N371I 41.38 0.53 0.0128
N371T 20.57 0.26 0.0127
S326I 576.25 3.37 0.0058
T280S 18.54 0.07 0.004
N371I removed KM(MCN) Vmax Vmax/KM(MCN)
164
(µM) (s-1) (µM -1 s-1)
TetX2 18 0.08 0.0044
T280A 5.92 0.12 0.0201
F235Y 84.65 0.52 0.0061
K64R 19.45 0.08 0.004
N371I 60.94 0.77 0.0126
N371T 16.21 0.24 0.0146
S326I 101.52 0.68 0.0067
T280S 16.8 0.07 0.0043
N371T removed KM(MCN) Vmax Vmax/KM(MCN)
(µM) (s-1) (µM -1 s-1)
TetX2 32.99 0.12 0.0036
T280A 6.52 0.13 0.0203
F235Y 111.91 0.65 0.0058
K64R 19.45 0.08 0.0041
N371I 36.07 0.5 0.0138
165
N371T 21.68 0.29 0.0134
S326I 93.13 0.62 0.0067
T280S 14.82 0.07 0.0047
S236I removed KM(MCN) Vmax Vmax/KM(MCN)
(µM) (s-1) (µM -1 s-1)
TetX2 35.25 0.13 0.0036
T280A 4.68 0.09 0.0195
F235Y 45.65 0.32 0.007
K64R 16.22 0.07 0.0042
N371I 53.34 0.72 0.0134
N371T 19.79 0.25 0.0125
S326I 86.29 0.63 0.0073
T280S 14.87 0.06 0.0043
T280S removed KM(MCN) Vmax Vmax/KM(MCN)
(µM) (s-1) (µM -1 s-1)
TetX2 25.96 0.09 0.0035
166
T280A 5.31 0.1 0.0187
F235Y 127.23 0.7 0.0055
K64R 13.28 0.06 0.0043
N371I 50.17 0.61 0.0121
N371T 30.87 0.32 0.0104
S326I 64.41 0.43 0.0066
T280S 16.7 0.07 0.0039
167
